data_1wxs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wxs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.063 0.459 . . . . 54.219999999999999 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.340000000000003 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.039999999999999 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 72.040000000000006 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 111.211 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.129999999999995 111.149 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.817 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.17 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.858 0.274 . . . . 73.019999999999996 112.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.150000000000006 110.907 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 72.540000000000006 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 71.129999999999995 110.919 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 72.230000000000004 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.409999999999997 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.530000000000001 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.310000000000002 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 75.230000000000004 111.082 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 73.329999999999998 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.07 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.083 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.519999999999996 110.864 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.319999999999993 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.439999999999998 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.219999999999999 111.05 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 73.219999999999999 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.921 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 74.25 112.643 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 75.099999999999994 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 73.010000000000005 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 75.200000000000003 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.209999999999994 111.061 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.040000000000006 111.083 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.010000000000005 111.125 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 64.209999999999994 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 74.120000000000005 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.430000000000007 110.83 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.340000000000003 112.379 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.519999999999996 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.150000000000006 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.219999999999999 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.200000000000003 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.178 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.129999999999995 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.099999999999994 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 72.010000000000005 110.805 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.310000000000002 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.219999999999999 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 74.439999999999998 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 71.420000000000002 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.400000000000006 111.281 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.129999999999995 111.137 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.439999999999998 112.217 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.985 0.421 . . . . 64.430000000000007 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 74.019999999999996 111.146 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.439999999999998 110.79 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.239999999999995 111.127 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 72.099999999999994 111.146 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.039999999999999 111.109 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.233 0.238 0 CA-C-O 120.77 0.238 . . . . 72.030000000000001 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.003 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 72.400000000000006 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.230000000000004 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.420000000000002 110.933 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.219999999999999 112.4 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.030000000000001 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.540000000000006 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.631 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 111.145 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.229999999999997 110.844 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.108 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 74.219999999999999 110.984 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 72.340000000000003 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.078 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.349999999999994 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 61.130000000000003 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 110.736 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 61.119999999999997 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 72.519999999999996 111.367 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.430000000000007 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 71.439999999999998 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.219999999999999 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.439999999999998 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 72.010000000000005 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 71.010000000000005 111.01 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 74.209999999999994 111.162 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.450000000000003 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.099999999999994 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.100000000000001 112.523 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.349999999999994 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.329999999999998 111.175 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.129999999999995 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.239999999999995 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 63.43 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 74.150000000000006 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 72.519999999999996 111.075 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.371 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.329999999999998 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 111.349 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.040000000000006 111.049 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 110.825 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 73.409999999999997 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.5 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.450000000000003 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.319999999999993 110.955 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 64.319999999999993 111.37 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.120000000000005 110.949 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 72.310000000000002 112.515 179.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.193 0.52 . . . . 70.519999999999996 110.615 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.439999999999998 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.329999999999998 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.319999999999993 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.897 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 111.235 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 111.395 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.140000000000001 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.030000000000001 111.246 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.623 0.176 . . . . 73.400000000000006 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 74.530000000000001 110.805 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.264 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 75.439999999999998 111.047 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.200000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 72.230000000000004 110.883 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.439999999999998 112.342 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 73.150000000000006 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.109999999999999 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.802 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.108 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.913 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.97 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.992 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.099999999999994 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.932 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 75.540000000000006 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.310000000000002 111.178 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.409999999999997 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.310000000000002 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.030000000000001 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.439999999999998 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.129999999999995 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.340000000000003 110.908 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 75.150000000000006 111.164 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.519999999999996 111.141 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.030000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 74.340000000000003 112.515 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 73.340000000000003 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 74.129999999999995 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.310000000000002 110.811 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 112.311 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.329999999999998 111.206 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 55.039999999999999 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.520000000000003 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.549999999999997 111.064 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.519999999999996 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 74.510000000000005 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.540000000000006 110.769 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.430000000000007 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.409999999999997 110.969 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.200000000000003 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 75.310000000000002 110.893 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 75.230000000000004 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 73.519999999999996 111.191 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 75.409999999999997 111.32 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 52.049999999999997 112.309 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.751 0.31 . . . . 74.310000000000002 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 74.340000000000003 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.400000000000006 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.129999999999995 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.843 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.319999999999993 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 75.200000000000003 111.047 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 121.112 0.38 . . . . 64.439999999999998 112.322 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.409999999999997 111.017 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 111.16 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 111.026 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 71.140000000000001 111.408 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.520000000000003 112.34 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.549999999999997 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.200000000000003 111.236 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.329999999999998 112.585 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 111.042 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 64.230000000000004 111.18 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.120000000000005 110.935 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.25 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.540000000000006 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.965 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.219999999999999 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 74.209999999999994 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 75.340000000000003 111.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 64.519999999999996 112.068 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 72.319999999999993 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.340000000000003 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.420000000000002 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.520000000000003 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.510000000000005 111.12 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 72.230000000000004 111.191 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.539999999999999 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.420000000000002 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.420000000000002 112.445 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.219999999999999 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 74.409999999999997 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.310000000000002 111.05 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.519999999999996 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.530000000000001 112.297 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.150000000000006 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 75.340000000000003 111.004 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.129999999999995 110.947 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 110.971 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.319999999999993 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 111.111 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.310000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.400000000000006 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.430000000000007 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.140000000000001 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.439999999999998 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.219999999999999 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.89 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 73.030000000000001 111.389 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 73.299999999999997 111.331 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.519999999999996 112.144 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.87 0.366 . . . . 71.439999999999998 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 72.430000000000007 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.299999999999997 111.255 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.129999999999995 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.86 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.109999999999999 111.088 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 111.027 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 CA--C 1.527 0.141 0 CA-C-O 120.87 0.279 . . . . 74.129999999999995 112.146 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.040000000000006 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 110.849 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 74.340000000000003 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 74.140000000000001 111.129 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.358 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.140000000000001 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.299999999999997 111.116 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 75.549999999999997 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 75.040000000000006 110.813 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.186 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.086 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 61.009999999999998 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.519999999999996 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.109999999999999 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 64.530000000000001 110.939 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.200000000000003 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 75.109999999999999 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 72.329999999999998 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.540000000000006 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 74.140000000000001 111.137 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.239999999999995 110.886 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 73.329999999999998 111.111 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.140000000000001 111.215 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.420000000000002 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 62.450000000000003 112.384 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.450000000000003 111.094 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 73.150000000000006 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 71.400000000000006 111.268 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.409999999999997 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.420000000000002 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 72.200000000000003 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 73.120000000000005 111.154 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.256 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.120000000000005 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 75.109999999999999 111.151 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.409999999999997 110.862 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 75.109999999999999 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.010000000000005 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.140000000000001 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.120000000000005 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.439999999999998 111.01 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.698 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 73.019999999999996 111.027 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 73.349999999999994 111.128 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.319999999999993 112.449 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 121.094 0.474 . . . . 74.209999999999994 110.75 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 65.340000000000003 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 54.119999999999997 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.299999999999997 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.94 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 71.549999999999997 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.150000000000006 111.179 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 111.091 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.846 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.111 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 CA--C 1.53 0.281 0 CA-C-O 120.853 0.272 . . . . 74.209999999999994 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.530000000000001 110.825 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.169 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.149999999999999 110.645 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.030000000000001 111.25 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.209999999999994 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 71.519999999999996 111.193 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 74.0 112.188 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.239999999999995 110.929 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.200000000000003 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 111.067 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.093 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.409999999999997 110.965 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 60.140000000000001 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 111.09 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.310000000000002 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 73.510000000000005 110.935 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 73.299999999999997 111.204 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 71.019999999999996 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.530000000000001 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.299999999999997 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 111.058 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 75.430000000000007 111.181 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 71.310000000000002 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.420000000000002 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 74.299999999999997 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.299999999999997 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.510000000000005 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 74.340000000000003 111.301 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 72.25 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 72.540000000000006 112.36 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.5 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.310000000000002 111.116 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 63.009999999999998 111.171 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.430000000000007 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 74.340000000000003 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 111.195 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 72.200000000000003 110.86 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 61.229999999999997 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 64.019999999999996 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 110.776 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.049999999999997 110.957 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.016 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 74.150000000000006 111.184 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 72.129999999999995 112.201 -179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.997 0.427 . . . . 73.129999999999995 110.865 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.239999999999995 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 75.209999999999994 110.709 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 71.049999999999997 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.973 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 52.520000000000003 111.256 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 74.540000000000006 111.192 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.234 0.292 0 CA-C-O 120.844 0.268 . . . . 74.319999999999993 112.363 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 111.051 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.099999999999994 111.026 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.866 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.329999999999998 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 74.120000000000005 111.155 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.239999999999995 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.040000000000006 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.329999999999998 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 110.735 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 111.113 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 111.263 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 72.120000000000005 111.016 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.030000000000001 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.064 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.349999999999994 111.121 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.299999999999997 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 64.010000000000005 110.906 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 62.140000000000001 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 73.299999999999997 111.165 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.140000000000001 112.398 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.119999999999997 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.439999999999998 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 74.319999999999993 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 75.400000000000006 111.17 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.104 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 70.439999999999998 111.113 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.120000000000005 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 72.109999999999999 112.485 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 74.439999999999998 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.310000000000002 112.716 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 65.439999999999998 111.16 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.230000000000004 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.5 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.340000000000003 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.310000000000002 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.019999999999996 111.221 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.109999999999999 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.150000000000006 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 74.450000000000003 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 111.187 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 75.530000000000001 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.150000000000006 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.319999999999993 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 64.540000000000006 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.209999999999994 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.859 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.349999999999994 110.855 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.219999999999999 110.777 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.439999999999998 110.966 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 74.019999999999996 111.339 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.049999999999997 112.306 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.742 0.306 . . . . 65.439999999999998 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.329999999999998 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 63.109999999999999 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 110.818 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 74.409999999999997 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.319999999999993 110.93 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 74.409999999999997 110.785 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 111.141 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 CA-C-O 120.674 0.197 . . . . 72.219999999999999 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.200000000000003 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.439999999999998 110.784 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.299999999999997 111.023 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.879 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.400000000000006 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.549999999999997 112.273 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 71.200000000000003 111.18 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 74.140000000000001 112.451 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 75.140000000000001 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 64.349999999999994 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 111.101 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.924 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 72.340000000000003 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.277 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.519999999999996 111.147 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 74.439999999999998 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.200000000000003 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.966 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.319999999999993 111.251 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.319999999999993 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 70.409999999999997 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.400000000000006 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.140000000000001 110.941 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.540000000000006 110.846 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.400000000000006 111.152 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.420000000000002 111.167 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.230000000000004 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.540000000000006 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.400000000000006 111.152 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.340000000000003 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.430000000000007 112.388 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 73.5 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.409999999999997 111.268 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.530000000000001 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.099999999999994 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.439999999999998 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.450000000000003 110.889 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.349999999999994 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.150000000000006 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 74.140000000000001 110.777 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.400000000000006 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.019 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 75.349999999999994 110.93 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.759 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.120000000000005 111.169 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 74.430000000000007 112.213 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 74.400000000000006 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.400000000000006 111.177 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 110.901 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.540000000000006 110.588 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.907 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 74.109999999999999 111.006 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 64.120000000000005 110.905 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.889 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.218 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 CA--C 1.522 -0.094 0 CA-C-O 120.735 0.223 . . . . 73.140000000000001 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 72.230000000000004 110.879 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.077 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.530000000000001 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 71.219999999999999 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 75.439999999999998 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.540000000000006 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.539999999999999 110.951 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.230000000000004 111.2 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 75.030000000000001 112.595 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.150000000000006 110.841 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.166 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 73.099999999999994 111.076 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.340000000000003 111.06 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.030000000000001 111.236 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.310000000000002 111.006 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.010000000000005 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 73.299999999999997 111.015 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 72.230000000000004 111.28 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 70.420000000000002 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 73.150000000000006 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.420000000000002 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 73.030000000000001 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 65.140000000000001 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.209999999999994 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.097 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 75.549999999999997 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.299999999999997 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 75.040000000000006 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.519999999999996 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.230000000000004 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 74.200000000000003 110.971 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.519999999999996 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.219999999999999 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 71.140000000000001 111.077 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.010000000000005 111.01 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 55.299999999999997 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.400000000000006 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.125 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 65.439999999999998 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.099999999999994 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.099999999999994 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 62.329999999999998 110.863 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.040000000000006 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.773 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.409999999999997 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.201 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 74.420000000000002 111.244 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.130000000000003 112.26 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.996 0.427 . . . . 74.420000000000002 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 74.030000000000001 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.540000000000006 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.019999999999996 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 111.148 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.120000000000005 111.077 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.737 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.9 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.539999999999999 111.067 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.906 0.294 . . . . 73.099999999999994 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.911 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 72.319999999999993 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 73.019999999999996 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 75.299999999999997 110.727 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 63.350000000000001 110.916 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.349999999999994 111.219 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.409999999999997 112.334 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 64.530000000000001 110.643 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.100000000000001 111.14 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.510000000000005 112.391 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.530000000000001 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 73.040000000000006 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 70.420000000000002 111.004 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 74.329999999999998 111.063 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 111.139 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 110.86 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 64.230000000000004 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.099999999999994 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 73.219999999999999 111.334 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.539999999999999 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 75.319999999999993 110.755 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 74.310000000000002 110.901 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 73.230000000000004 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.329999999999998 111.102 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.439999999999998 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.299999999999997 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.085 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.319999999999993 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 111.074 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.340000000000003 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 70.030000000000001 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.540000000000006 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 73.109999999999999 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 74.25 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.239999999999995 111.085 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 71.019999999999996 112.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.299999999999997 111.356 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 111.218 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.230000000000004 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 63.329999999999998 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 73.030000000000001 111.212 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 72.340000000000003 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 75.530000000000001 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 75.030000000000001 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 74.530000000000001 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.329999999999998 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.219999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.450000000000003 111.176 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 70.409999999999997 111.286 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 74.030000000000001 112.386 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.496 0.498 . . . . 63.039999999999999 112.814 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.4 120.84 7.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.673 2.249 . . . . 45.119999999999997 112.275 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mt -137.84 145.56 42.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.992 -0.549 . . . . 75.129999999999995 110.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.04 104.28 0.19 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.531 -0.842 . . . . 73.109999999999999 112.395 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.2 m -151.26 173.31 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 71.120000000000005 110.979 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp -178.76 -36.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.259 -0.428 . . . . 74.430000000000007 110.833 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -151.03 126.35 10.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.459 . . . . 54.219999999999999 110.686 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.430000000000007 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.340000000000003 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.039999999999999 111.014 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 72.040000000000006 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 111.211 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.129999999999995 111.149 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.817 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.03 -35.39 2.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.17 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.73 30.13 6.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 55.229999999999997 110.819 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.15 160.48 65.51 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.699 0.761 . . . . 72.430000000000007 110.859 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.61 -31.89 20.3 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.793 2.329 . . . . 71.430000000000007 112.273 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -70.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 74.200000000000003 110.835 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.33 160.67 31.39 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 121.503 0.668 . . . . 75.519999999999996 111.161 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.97 -170.93 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.578 2.185 . . . . 73.019999999999996 112.111 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.150000000000006 110.907 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 72.540000000000006 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 71.129999999999995 110.919 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 72.230000000000004 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.409999999999997 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.530000000000001 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.310000000000002 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 75.230000000000004 111.082 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 73.329999999999998 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 74.409999999999997 111.07 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 111.103 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.083 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.519999999999996 110.864 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.319999999999993 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.439999999999998 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.219999999999999 111.05 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 73.219999999999999 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 75.439999999999998 110.921 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 74.25 112.643 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 75.099999999999994 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 73.010000000000005 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 75.200000000000003 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.209999999999994 111.061 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.040000000000006 111.083 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.010000000000005 111.125 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 64.209999999999994 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 74.120000000000005 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.430000000000007 110.83 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.340000000000003 112.379 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.519999999999996 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.150000000000006 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 63.219999999999999 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.219999999999999 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.200000000000003 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.178 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.129999999999995 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.099999999999994 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 72.010000000000005 110.805 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.310000000000002 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.219999999999999 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 74.439999999999998 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 71.420000000000002 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.400000000000006 111.281 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.129999999999995 111.137 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.1 144.63 52.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.439999999999998 112.217 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -100.41 -31.19 11.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.391 . . . . 73.239999999999995 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 173.75 12.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 64.200000000000003 110.847 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.99 151.75 33.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 110.856 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.16 -42.63 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.154 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 64.109999999999999 112.509 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.281 0.378 . . . . 74.140000000000001 112.739 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.68 28.52 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.531 2.154 . . . . 64.319999999999993 112.419 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -126.83 163.46 23.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.942 0.401 . . . . 70.109999999999999 110.85 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 130.92 -164.63 23.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.876 -0.678 . . . . 54.109999999999999 112.509 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.7 m -95.27 -60.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.459 . . . . 71.420000000000002 110.997 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm -173.77 58.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 75.340000000000003 110.846 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -172.86 125.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 64.430000000000007 111.0 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 74.019999999999996 111.146 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 110.793 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.439999999999998 110.79 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.239999999999995 111.127 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 72.099999999999994 111.146 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.78 -30.88 0.01 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.039999999999999 111.109 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t 68.78 9.98 7.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.037 0.446 . . . . 72.340000000000003 110.921 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.74 161.9 0.11 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 72.400000000000006 110.924 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 -14.29 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.854 2.369 . . . . 65.510000000000005 112.289 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -158.81 -41.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.96 0.41 . . . . 72.010000000000005 110.98 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -56.86 162.63 3.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 73.510000000000005 110.937 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.63 167.57 23.9 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.678 2.252 . . . . 72.030000000000001 112.548 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.003 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 72.400000000000006 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.230000000000004 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.420000000000002 110.933 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.219999999999999 112.4 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.030000000000001 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.540000000000006 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.631 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 55.009999999999998 111.145 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.229999999999997 110.844 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.108 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 74.219999999999999 110.984 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 72.340000000000003 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.078 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.349999999999994 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 61.130000000000003 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 110.736 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 61.119999999999997 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 72.519999999999996 111.367 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.430000000000007 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 71.439999999999998 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.219999999999999 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.439999999999998 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 72.010000000000005 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 71.010000000000005 111.01 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 74.209999999999994 111.162 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.450000000000003 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.099999999999994 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.100000000000001 112.523 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.349999999999994 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.329999999999998 111.175 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.129999999999995 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.239999999999995 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 63.43 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 74.150000000000006 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 72.519999999999996 111.075 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.371 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.329999999999998 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 111.349 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.040000000000006 111.049 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 110.825 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 73.409999999999997 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.5 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.450000000000003 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.319999999999993 110.955 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 75.5 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 64.319999999999993 111.37 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.120000000000005 110.949 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.51 133.14 25.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 72.310000000000002 112.515 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.67 174.0 8.28 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.054 -0.521 . . . . 75.120000000000005 110.899 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 t0 57.93 -176.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 75.310000000000002 110.87 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -44.56 7.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 73.439999999999998 110.961 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.99 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.983 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.943 -0.646 . . . . 72.109999999999999 112.474 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-O 121.318 0.399 . . . . 53.219999999999999 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.97 -171.3 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.581 2.188 . . . . 73.430000000000007 112.186 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.73 167.7 6.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 75.409999999999997 111.017 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -131.21 143.61 15.07 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.925 -0.655 . . . . 62.020000000000003 112.583 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.88 141.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.879 0.371 . . . . 73.239999999999995 110.787 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt -62.37 -62.7 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.5 110.767 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.66 136.33 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 70.519999999999996 110.615 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.439999999999998 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.329999999999998 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.319999999999993 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.897 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 111.235 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 71.439999999999998 111.395 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 73.140000000000001 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.89 -40.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 72.030000000000001 111.246 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.1 31.03 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 74.430000000000007 110.815 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.13 161.18 0.76 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.568 0.699 . . . . 74.439999999999998 110.832 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -33.61 15.95 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.696 2.264 . . . . 73.129999999999995 112.186 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -55.91 -70.15 0.12 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.174 -0.467 . . . . 75.540000000000006 110.811 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.49 160.4 26.37 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.6 0.714 . . . . 71.230000000000004 110.886 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.86 -178.16 2.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 73.400000000000006 112.303 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 74.530000000000001 110.805 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 111.264 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 75.439999999999998 111.047 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.200000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 72.230000000000004 110.883 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.439999999999998 112.342 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 73.150000000000006 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.109999999999999 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.802 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.108 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.913 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.97 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 71.400000000000006 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.992 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.099999999999994 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.932 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 75.540000000000006 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.310000000000002 111.178 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.409999999999997 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.310000000000002 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.030000000000001 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.439999999999998 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.129999999999995 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.340000000000003 110.908 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 75.150000000000006 111.164 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 73.519999999999996 111.141 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.030000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 74.340000000000003 112.515 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 73.340000000000003 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 74.129999999999995 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.310000000000002 110.811 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 112.311 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 62.119999999999997 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 75.310000000000002 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.329999999999998 111.206 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 55.039999999999999 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.520000000000003 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.549999999999997 111.064 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.519999999999996 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 74.510000000000005 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.540000000000006 110.769 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.430000000000007 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.409999999999997 110.969 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.200000000000003 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 75.310000000000002 110.893 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 75.230000000000004 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 73.519999999999996 111.191 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 75.409999999999997 111.32 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 131.32 20.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 52.049999999999997 112.309 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.13 143.76 45.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.867 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 62.0 179.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 60.020000000000003 110.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -130.99 175.18 9.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 110.758 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.87 169.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 111.146 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.614 -0.803 . . . . 75.340000000000003 112.416 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.491 0.495 . . . . 74.340000000000003 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.75 157.28 60.96 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.581 2.187 . . . . 71.230000000000004 112.414 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 21.0 mt -119.12 68.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 71.510000000000005 110.806 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.84 -147.51 15.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 73.439999999999998 112.576 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -143.47 82.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.01 0.434 . . . . 74.310000000000002 110.824 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -60.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 73.010000000000005 110.998 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -179.36 149.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 74.310000000000002 111.044 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 74.340000000000003 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.400000000000006 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.129999999999995 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.843 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.319999999999993 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -175.82 -34.81 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 75.200000000000003 111.047 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p 49.49 50.19 18.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 110.779 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -51.56 153.62 3.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.572 0.701 . . . . 65.109999999999999 110.981 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.73 149.25 66.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.729 2.286 . . . . 74.25 112.346 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 53.53 44.79 29.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.609 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.31 160.24 18.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.326 0.584 . . . . 72.230000000000004 111.005 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.54 -170.8 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.632 2.222 . . . . 64.439999999999998 112.322 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.409999999999997 111.017 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 111.16 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 111.026 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 71.140000000000001 111.408 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.520000000000003 112.34 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.549999999999997 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.200000000000003 111.236 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.329999999999998 112.585 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 111.042 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 64.230000000000004 111.18 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.120000000000005 110.935 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.25 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.540000000000006 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 110.965 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.219999999999999 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 74.209999999999994 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 75.340000000000003 111.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 64.519999999999996 112.068 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 72.319999999999993 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.340000000000003 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.420000000000002 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.520000000000003 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.510000000000005 111.12 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 72.230000000000004 111.191 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.539999999999999 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.420000000000002 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.420000000000002 112.445 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.219999999999999 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 74.409999999999997 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.310000000000002 111.05 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.519999999999996 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.530000000000001 112.297 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.150000000000006 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 75.340000000000003 111.004 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.129999999999995 110.947 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 110.971 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.319999999999993 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 111.111 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.310000000000002 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.400000000000006 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.430000000000007 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.140000000000001 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.439999999999998 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.219999999999999 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.89 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 73.030000000000001 111.389 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 73.299999999999997 111.331 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.06 146.43 58.33 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.519999999999996 112.144 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -91.86 -35.12 14.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 75.239999999999995 110.872 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.22 90.49 0.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 111.002 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.28 -62.09 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.445 -0.343 . . . . 73.230000000000004 111.112 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -57.07 174.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 72.420000000000002 111.234 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 C-N-CA 120.583 -0.818 . . . . 54.450000000000003 112.537 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 121.359 0.422 . . . . 75.310000000000002 112.636 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.09 -174.18 0.92 Allowed 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 2.274 . . . . 74.209999999999994 112.282 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.64 79.9 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.926 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -62.53 155.57 40.45 Favored Glycine 0 C--O 1.229 -0.187 0 C-N-CA 120.653 -0.784 . . . . 73.120000000000005 112.534 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.2 m -163.08 63.62 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 70.439999999999998 110.936 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt -117.41 -57.14 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.861 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -163.65 69.28 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 71.439999999999998 110.436 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 72.430000000000007 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.299999999999997 111.255 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.129999999999995 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.86 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.109999999999999 111.088 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 111.027 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.12 -37.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t 51.14 52.4 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.420000000000002 110.867 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.82 160.55 0.78 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.515 0.674 . . . . 74.319999999999993 110.854 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -44.07 2.26 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.561 2.174 . . . . 71.129999999999995 112.329 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -75.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.982 0.42 . . . . 75.109999999999999 110.903 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.64 160.6 36.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.557 0.694 . . . . 71.230000000000004 110.928 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.03 -170.78 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.699 2.266 . . . . 74.129999999999995 112.146 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.040000000000006 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 110.849 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 74.340000000000003 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 74.140000000000001 111.129 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.358 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.140000000000001 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.299999999999997 111.116 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 75.549999999999997 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 75.040000000000006 110.813 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.186 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.086 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 61.009999999999998 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.519999999999996 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 72.109999999999999 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 64.530000000000001 110.939 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.200000000000003 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 75.109999999999999 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 72.329999999999998 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.540000000000006 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 74.140000000000001 111.137 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.239999999999995 110.886 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 73.329999999999998 111.111 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.140000000000001 111.215 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.420000000000002 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 62.450000000000003 112.384 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.450000000000003 111.094 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 73.150000000000006 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 71.400000000000006 111.268 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.409999999999997 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.420000000000002 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 72.200000000000003 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 73.120000000000005 111.154 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.256 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.120000000000005 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.299999999999997 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 75.109999999999999 111.151 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.409999999999997 110.862 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 75.109999999999999 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.010000000000005 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.140000000000001 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.120000000000005 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.439999999999998 111.01 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.239999999999995 110.698 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 73.019999999999996 111.027 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 73.349999999999994 111.128 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 118.32 5.61 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.319999999999993 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 tmm_? -63.44 -37.42 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 75.329999999999998 110.843 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.09 33.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 74.540000000000006 110.762 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.22 -174.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.099999999999994 110.843 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.43 144.61 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 111.115 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 C-N-CA 120.765 -0.731 . . . . 73.230000000000004 112.474 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 CA-C-O 121.332 0.407 . . . . 63.210000000000001 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 -46.53 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.597 2.198 . . . . 71.239999999999995 112.31 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.46 175.01 8.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 110.879 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 65.22 57.74 11.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 73.439999999999998 112.746 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.5 132.4 31.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.026 0.441 . . . . 65.109999999999999 110.739 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm -95.74 88.76 5.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 73.310000000000002 110.776 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.03 152.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.094 0.474 . . . . 74.209999999999994 110.75 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 65.340000000000003 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 54.119999999999997 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.299999999999997 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.94 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 71.549999999999997 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.150000000000006 111.179 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 111.091 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.846 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.44 -40.11 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.111 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.16 29.39 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 74.319999999999993 110.853 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.75 160.6 43.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.75 0.786 . . . . 74.409999999999997 110.811 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.59 28.46 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.66 2.24 . . . . 61.210000000000001 112.413 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -61.44 -67.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.844 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.43 160.29 26.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 121.607 0.718 . . . . 75.329999999999998 110.832 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.63 -179.86 3.14 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.698 2.265 . . . . 74.209999999999994 112.228 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.530000000000001 110.825 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.169 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.149999999999999 110.645 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.030000000000001 111.25 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.209999999999994 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 71.519999999999996 111.193 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 74.0 112.188 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.239999999999995 110.929 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.200000000000003 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 70.329999999999998 111.067 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.093 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.409999999999997 110.965 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 60.140000000000001 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 111.09 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.310000000000002 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 73.510000000000005 110.935 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 73.299999999999997 111.204 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 71.019999999999996 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.530000000000001 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.299999999999997 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 111.058 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 75.430000000000007 111.181 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 71.310000000000002 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.420000000000002 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 74.299999999999997 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.299999999999997 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.510000000000005 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 74.340000000000003 111.301 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 72.25 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 72.540000000000006 112.36 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 75.5 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.310000000000002 111.116 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 63.009999999999998 111.171 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.430000000000007 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 74.340000000000003 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 111.195 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 72.200000000000003 110.86 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 74.219999999999999 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 61.229999999999997 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 64.019999999999996 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 110.776 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.049999999999997 110.957 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.016 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 74.150000000000006 111.184 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 148.01 63.83 Favored 'Trans proline' 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 72.129999999999995 112.201 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 171.58 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.985 -0.552 . . . . 74.329999999999998 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.5 -172.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.030000000000001 110.943 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -116.7 90.35 3.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.329 -0.396 . . . . 73.540000000000006 110.886 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.82 167.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.01 -0.541 . . . . 71.219999999999999 110.939 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 C-N-CA 120.462 -0.875 . . . . 64.540000000000006 112.499 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.632 0.573 . . . . 74.109999999999999 112.76 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.7 145.73 58.36 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.744 2.296 . . . . 74.329999999999998 112.174 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 73.439999999999998 111.165 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 153.56 87.09 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.83 -0.7 . . . . 60.340000000000003 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.52 175.87 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.786 0.327 . . . . 72.129999999999995 110.91 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt -110.08 -54.73 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.86 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -90.61 112.69 24.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 73.129999999999995 110.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.239999999999995 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 75.209999999999994 110.709 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 71.049999999999997 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.973 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 52.520000000000003 111.256 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.77 -35.18 2.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 74.540000000000006 111.192 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.83 29.27 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 75.510000000000005 110.797 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.77 160.55 43.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.241 0.544 . . . . 75.150000000000006 110.955 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -31.45 20.55 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.632 2.222 . . . . 60.149999999999999 112.462 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -52.11 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.66 160.63 25.49 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.665 0.745 . . . . 74.5 110.865 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.59 10.74 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.618 2.212 . . . . 74.319999999999993 112.363 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 111.051 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.099999999999994 111.026 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 75.310000000000002 110.866 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.329999999999998 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 74.120000000000005 111.155 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.239999999999995 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.040000000000006 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.329999999999998 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 110.735 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 111.113 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 111.263 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 72.120000000000005 111.016 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.030000000000001 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.064 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.349999999999994 111.121 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.299999999999997 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 64.010000000000005 110.906 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 62.140000000000001 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 73.299999999999997 111.165 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.140000000000001 112.398 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.119999999999997 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.439999999999998 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 74.319999999999993 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 75.400000000000006 111.17 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.0 111.104 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 70.439999999999998 111.113 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.120000000000005 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 72.109999999999999 112.485 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 74.439999999999998 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.310000000000002 112.716 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 65.439999999999998 111.16 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.230000000000004 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.5 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.340000000000003 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.310000000000002 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.019999999999996 111.221 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.109999999999999 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.150000000000006 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 74.450000000000003 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 111.187 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 75.530000000000001 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.150000000000006 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.319999999999993 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 64.540000000000006 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.209999999999994 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.859 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.349999999999994 110.855 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.219999999999999 110.777 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.439999999999998 110.966 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 74.019999999999996 111.339 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.51 1.87 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.049999999999997 112.306 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -52.13 -47.17 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.5 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.39 26.66 1.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.997 -0.547 . . . . 64.340000000000003 110.873 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 51.88 84.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.093 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.94 146.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 74.340000000000003 111.266 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.756 . . . . 61.109999999999999 112.618 -179.852 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.081 0 CA-C-O 121.516 0.509 . . . . 52.530000000000001 112.363 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -178.72 2.44 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.775 2.317 . . . . 74.400000000000006 112.286 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 13.2 tp -120.52 -45.67 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 73.319999999999993 111.01 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.71 -47.25 4.3 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.759 -0.734 . . . . 65.230000000000004 112.425 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.2 m 63.1 34.39 13.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 71.030000000000001 110.885 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -113.6 57.88 0.68 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 111.554 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -163.41 73.52 0.32 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.807 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.329999999999998 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 63.109999999999999 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 64.140000000000001 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 110.818 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 74.409999999999997 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.319999999999993 110.93 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 74.409999999999997 110.785 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 9.66 2.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 111.141 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.06 16.29 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 75.239999999999995 110.846 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 61.4 162.7 0.11 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.310000000000002 110.741 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.97 -48.71 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.977 2.451 . . . . 73.409999999999997 112.293 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -130.35 65.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 72.319999999999993 110.966 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.15 160.39 6.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.63 0.729 . . . . 62.439999999999998 110.971 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.9 -53.15 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.692 2.262 . . . . 72.219999999999999 112.105 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.200000000000003 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.439999999999998 110.784 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.299999999999997 111.023 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.879 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.400000000000006 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.549999999999997 112.273 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 71.200000000000003 111.18 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 74.140000000000001 112.451 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 75.140000000000001 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 64.349999999999994 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 111.101 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.924 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 72.340000000000003 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.277 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.519999999999996 111.147 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 74.439999999999998 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.200000000000003 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.966 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.319999999999993 111.251 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.319999999999993 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 70.409999999999997 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.400000000000006 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.140000000000001 110.941 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.540000000000006 110.846 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.400000000000006 111.152 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.420000000000002 111.167 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.230000000000004 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.540000000000006 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.400000000000006 111.152 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.340000000000003 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.430000000000007 112.388 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 73.5 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.409999999999997 111.268 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.530000000000001 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.099999999999994 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.439999999999998 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.450000000000003 110.889 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.349999999999994 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.150000000000006 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 74.140000000000001 110.777 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.400000000000006 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 75.510000000000005 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.019 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 75.349999999999994 110.93 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.759 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.120000000000005 111.169 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 130.84 19.89 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 74.430000000000007 112.213 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -35.66 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 74.420000000000002 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -119.59 146.04 45.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.336 -0.393 . . . . 73.310000000000002 110.917 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 57.9 87.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 75.230000000000004 111.029 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 m -114.65 158.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 110.983 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.291 0 C-N-CA 120.649 -0.786 . . . . 71.530000000000001 112.489 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 CA-C-O 121.353 0.418 . . . . 60.240000000000002 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 141.98 46.4 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.845 2.364 . . . . 71.450000000000003 112.221 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.1 124.74 42.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 63.32 110.887 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -109.13 100.66 1.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 74.420000000000002 112.332 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.31 138.85 21.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.844 0.354 . . . . 75.329999999999998 110.914 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.98 -57.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 74.349999999999994 110.88 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -125.39 142.34 51.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 74.400000000000006 111.053 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.400000000000006 111.177 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 110.901 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.540000000000006 110.588 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.907 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 74.109999999999999 111.006 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 64.120000000000005 110.905 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.889 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -162.07 -35.66 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.218 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.74 7.27 6.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 110.811 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.13 162.63 0.1 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.647 0.737 . . . . 74.219999999999999 110.734 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.9 -9.45 26.09 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.871 2.381 . . . . 73.510000000000005 112.177 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -163.72 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 75.140000000000001 110.822 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 162.67 1.35 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.495 0.664 . . . . 71.400000000000006 111.026 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.48 169.76 17.81 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.649 2.232 . . . . 73.140000000000001 112.543 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 72.230000000000004 110.879 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 72.209999999999994 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.077 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.530000000000001 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.019999999999996 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 71.219999999999999 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 75.439999999999998 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.540000000000006 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.539999999999999 110.951 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.230000000000004 111.2 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 75.030000000000001 112.595 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.150000000000006 110.841 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.166 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 73.099999999999994 111.076 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.340000000000003 111.06 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.030000000000001 111.236 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 71.430000000000007 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.310000000000002 111.006 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.010000000000005 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 73.299999999999997 111.015 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 72.230000000000004 111.28 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 70.420000000000002 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 73.150000000000006 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.420000000000002 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 73.030000000000001 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 65.140000000000001 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.209999999999994 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.097 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 75.549999999999997 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.299999999999997 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 75.040000000000006 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.519999999999996 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.230000000000004 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 74.200000000000003 110.971 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.519999999999996 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.219999999999999 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 71.140000000000001 111.077 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.010000000000005 111.01 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 55.299999999999997 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.400000000000006 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.125 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 65.439999999999998 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.099999999999994 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.099999999999994 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 62.329999999999998 110.863 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.040000000000006 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.773 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.409999999999997 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.201 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 74.420000000000002 111.244 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.0 150.01 66.13 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.130000000000003 112.26 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -38.2 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 75.049999999999997 110.932 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.93 143.98 28.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.868 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 -174.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 110.885 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.22 103.48 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.488 . . . . 75.109999999999999 111.165 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.746 -0.74 . . . . 65.340000000000003 112.618 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 121.402 0.445 . . . . 64.409999999999997 112.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 80.76 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.762 2.308 . . . . 72.049999999999997 112.236 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.8 176.2 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 70.310000000000002 110.896 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 164.8 140.39 2.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 112.465 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.7 p -104.76 93.43 4.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 62.549999999999997 110.804 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.14 -70.68 0.27 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.101 -0.5 . . . . 74.140000000000001 110.914 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -120.93 31.5 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 74.420000000000002 110.875 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 74.510000000000005 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 74.030000000000001 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.540000000000006 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.019999999999996 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 111.148 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.120000000000005 111.077 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.737 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.9 m -117.57 -24.58 7.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.539999999999999 111.067 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.1 8.23 6.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.942 0.401 . . . . 55.399999999999999 110.723 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.11 59.13 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.419 0.628 . . . . 73.420000000000002 110.667 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.71 -26.27 27.97 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.666 2.244 . . . . 75.439999999999998 112.21 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.33 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 110.902 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -177.56 -61.79 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 71.540000000000006 110.97 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 16' ' ' LEU . 53.5 Cg_endo -69.77 -167.72 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.555 2.17 . . . . 73.099999999999994 112.329 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.911 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 72.319999999999993 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 73.019999999999996 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 75.299999999999997 110.727 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 63.350000000000001 110.916 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.349999999999994 111.219 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.409999999999997 112.334 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 64.530000000000001 110.643 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.100000000000001 111.14 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.510000000000005 112.391 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.530000000000001 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 73.040000000000006 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 70.420000000000002 111.004 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 74.329999999999998 111.063 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 111.139 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 75.129999999999995 110.86 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 64.230000000000004 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.099999999999994 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 73.219999999999999 111.334 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.539999999999999 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 75.319999999999993 110.755 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 74.310000000000002 110.901 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 73.230000000000004 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.329999999999998 111.102 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.439999999999998 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.299999999999997 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.085 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.319999999999993 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 75.340000000000003 111.074 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.340000000000003 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 70.030000000000001 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.540000000000006 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 73.109999999999999 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 74.25 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.239999999999995 111.085 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 110.927 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 71.019999999999996 112.399 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.299999999999997 111.356 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 111.218 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.230000000000004 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 63.329999999999998 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 73.030000000000001 111.212 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 72.340000000000003 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 75.530000000000001 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 75.030000000000001 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 74.530000000000001 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.329999999999998 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.219999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.450000000000003 111.176 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 70.409999999999997 111.286 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.6 88.81 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 74.030000000000001 112.386 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -75.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -169.15 61.88 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 75.540000000000006 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.63 129.8 55.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.865 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.06 153.99 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.074 0.464 . . . . 74.230000000000004 110.99 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 62.509999999999998 112.532 179.753 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.063 0.459 . . . . 53.530000000000001 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.340000000000003 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.039999999999999 111.014 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 64.030000000000001 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 21' ' ' LEU . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 73.329999999999998 111.211 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.129999999999995 111.149 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.817 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 71.420000000000002 111.17 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.858 0.274 . . . . 73.019999999999996 112.111 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.150000000000006 110.907 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 72.319999999999993 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 71.030000000000001 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 62.240000000000002 110.919 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 60.450000000000003 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.409999999999997 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.329999999999998 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 63.329999999999998 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.310000000000002 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' HG11 ' A' ' 66' ' ' VAL . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.082 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 55.5 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' PRO . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.07 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 49' ' ' ILE . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 53.420000000000002 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.083 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.519999999999996 110.864 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.319999999999993 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.340000000000003 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' A' ' 10' ' ' LEU . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.219999999999999 111.05 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 64.430000000000007 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.552 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 74.450000000000003 110.921 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 76' ' ' ILE . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 55.030000000000001 112.643 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 53.310000000000002 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 72.109999999999999 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 63.229999999999997 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.209999999999994 111.061 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.040000000000006 111.083 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 70' ' ' HIS . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.010000000000005 111.125 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 44.299999999999997 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 72.120000000000005 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.599 HD13 ' CD2' ' A' ' 70' ' ' HIS . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.230000000000004 110.83 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.340000000000003 112.379 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 55.020000000000003 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.150000000000006 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 53.219999999999999 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 72.049999999999997 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.219999999999999 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.200000000000003 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG11 ' CE2' ' A' ' 29' ' ' PHE . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 72.349999999999994 111.178 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.129999999999995 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 63.119999999999997 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 57' ' ' ILE . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 71.239999999999995 110.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.310000000000002 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.219999999999999 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 65.040000000000006 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 54.130000000000003 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 77' ' ' ILE . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.209999999999994 111.281 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.129999999999995 111.137 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.439999999999998 112.217 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.985 0.421 . . . . 64.430000000000007 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 62.140000000000001 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.442 HG21 ' HA2' ' A' ' 64' ' ' GLY . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 64.319999999999993 111.146 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 8' ' ' ILE . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 110.793 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 73.319999999999993 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.582 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.400000000000006 110.79 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 111.127 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 52.109999999999999 111.146 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.039999999999999 111.109 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.233 0.238 0 CA-C-O 120.77 0.238 . . . . 72.030000000000001 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.735 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.003 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 71.340000000000003 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.230000000000004 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 24' ' ' PRO . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.420000000000002 110.933 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 23' ' ' VAL . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.219999999999999 112.4 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.030000000000001 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.239999999999995 112.548 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.631 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 54.109999999999999 111.145 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.229999999999997 110.844 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' PRO . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.108 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 63.119999999999997 110.984 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 54.329999999999998 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.078 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.349999999999994 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 60.520000000000003 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' HB3' HD22 ' A' ' 10' ' ' LEU . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 53.219999999999999 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 63.539999999999999 111.367 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.430000000000007 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 54.210000000000001 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.129999999999995 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.439999999999998 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 63.530000000000001 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.735 HD13 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 41.340000000000003 111.01 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA2' ' A' ' 54' ' ' GLY . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 61.520000000000003 111.162 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 72.409999999999997 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.099999999999994 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.100000000000001 112.523 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.349999999999994 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 HG12 ' A' ' 66' ' ' VAL . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.329999999999998 111.175 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.129999999999995 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.239999999999995 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 52.530000000000001 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 62.310000000000002 110.988 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.743 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 63.5 111.075 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 4' ' ' VAL . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.371 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.329999999999998 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 62' ' ' THR . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 63.43 111.349 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 54.439999999999998 111.049 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 110.825 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 61.520000000000003 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.409999999999997 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.450000000000003 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 8' ' ' ILE . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.319999999999993 110.955 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 73.040000000000006 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 53.43 111.37 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.120000000000005 110.949 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 52.420000000000002 112.515 179.707 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.193 0.52 . . . . 70.519999999999996 110.615 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.439999999999998 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 64.200000000000003 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.319999999999993 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.897 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 6' ' ' PHE . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 71.340000000000003 111.235 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 18' ' ' TYR . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 53.399999999999999 111.395 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 64.239999999999995 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 54.340000000000003 111.246 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.623 0.176 . . . . 73.400000000000006 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.784 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 73.409999999999997 110.805 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 54.039999999999999 111.264 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 111.047 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.200000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' HD2' ' A' ' 24' ' ' PRO . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 44.0 110.883 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 23' ' ' VAL . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.439999999999998 112.342 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 70.340000000000003 111.168 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.109999999999999 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.648 ' CE1' HG11 ' A' ' 66' ' ' VAL . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.802 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.108 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.913 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 44.420000000000002 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 43.549999999999997 110.97 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 42.299999999999997 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 110.992 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.099999999999994 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' ALA . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.932 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 60.229999999999997 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG11 ' CG2' ' A' ' 76' ' ' ILE . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.310000000000002 111.178 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.409999999999997 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.310000000000002 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.030000000000001 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.439999999999998 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.129999999999995 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.688 HD12 HD11 ' A' ' 33' ' ' LEU . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.340000000000003 110.908 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.649 HD12 ' HA2' ' A' ' 54' ' ' GLY . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 64.019999999999996 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 71.540000000000006 111.141 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.030000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 44.549999999999997 112.515 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 64.200000000000003 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 52.219999999999999 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.310000000000002 110.811 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 112.311 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 43.420000000000002 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 44.409999999999997 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.586 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.329999999999998 111.206 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 23.140000000000001 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.520000000000003 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.648 HG11 ' CE1' ' A' ' 29' ' ' PHE . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.549999999999997 111.064 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 71.219999999999999 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.519999999999996 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 64.239999999999995 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.540000000000006 110.769 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.430000000000007 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.658 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.409999999999997 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.200000000000003 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' SER . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.893 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.71 ' CG2' HG11 ' A' ' 42' ' ' VAL . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 70.239999999999995 111.191 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 50' ' ' ILE . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 74.439999999999998 111.32 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 33.530000000000001 112.309 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.751 0.31 . . . . 63.340000000000003 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 70.209999999999994 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.400000000000006 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.129999999999995 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 18' ' ' TYR . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.843 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.340000000000003 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 74.25 111.047 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 121.112 0.38 . . . . 61.200000000000003 112.322 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.409999999999997 111.017 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 111.16 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 20' ' ' VAL . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 62.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 62.399999999999999 111.408 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.520000000000003 112.34 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.549999999999997 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.200000000000003 111.236 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.329999999999998 112.585 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.030000000000001 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.042 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 27' ' ' THR . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.030000000000001 111.18 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.120000000000005 110.935 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.540000000000006 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.229999999999997 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 110.965 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.219999999999999 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 70.310000000000002 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 63.420000000000002 111.354 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.66 ' O ' HD11 ' A' ' 76' ' ' ILE . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 61.399999999999999 112.068 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.340000000000003 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.420000000000002 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.520000000000003 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.510000000000005 111.12 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA2' ' A' ' 54' ' ' GLY . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 64.219999999999999 111.191 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.539999999999999 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.676 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.420000000000002 112.445 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.219999999999999 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 72.120000000000005 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 HG12 ' A' ' 66' ' ' VAL . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.310000000000002 111.05 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.519999999999996 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.129999999999995 112.297 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.150000000000006 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 64.239999999999995 111.004 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.129999999999995 110.947 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 34.229999999999997 110.971 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.319999999999993 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 71.319999999999993 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 70.430000000000007 111.111 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.210000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.120000000000005 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 53.43 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.430000000000007 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.130000000000003 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.439999999999998 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.219999999999999 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.58 ' NH1' HD11 ' A' ' 50' ' ' ILE . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.89 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 43' ' ' PRO . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 71.349999999999994 111.389 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ILE . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 70.319999999999993 111.331 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.140000000000001 112.144 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.87 0.366 . . . . 71.439999999999998 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 65.549999999999997 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 67' ' ' PHE . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.299999999999997 111.255 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.129999999999995 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.86 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 76' ' ' ILE . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.109999999999999 111.088 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.027 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 CA--C 1.527 0.141 0 CA-C-O 120.87 0.279 . . . . 74.129999999999995 112.146 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.71 ' HB2' HG22 ' A' ' 9' ' ' THR . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.040000000000006 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 6' ' ' PHE . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 72.519999999999996 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 71.510000000000005 111.129 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.358 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.140000000000001 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.140000000000001 111.116 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 45.009999999999998 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.726 ' CE1' HG11 ' A' ' 66' ' ' VAL . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 61.399999999999999 110.813 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.186 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.086 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 44.049999999999997 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 HG13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 61.130000000000003 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.210000000000001 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 76' ' ' ILE . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 32.219999999999999 110.939 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.149999999999999 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 74.530000000000001 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.783 HG11 HG22 ' A' ' 76' ' ' ILE . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 63.109999999999999 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.209999999999994 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.140000000000001 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.540000000000006 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 64.510000000000005 111.137 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.655 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.239999999999995 110.886 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' HA2' ' A' ' 54' ' ' GLY . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 62.43 111.111 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 55' ' ' ILE . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.140000000000001 111.215 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.420000000000002 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 53.130000000000003 112.384 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.75 HG22 ' OG1' ' A' ' 51' ' ' THR . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.450000000000003 111.094 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 65.439999999999998 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 HD11 ' CG2' ' A' ' 51' ' ' THR . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 70.310000000000002 111.268 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.409999999999997 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.409999999999997 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 52.43 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 72.150000000000006 111.154 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.256 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.120000000000005 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.239999999999995 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG11 ' CE1' ' A' ' 29' ' ' PHE . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 72.140000000000001 111.151 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 4' ' ' VAL . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.409999999999997 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 71.109999999999999 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.010000000000005 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.140000000000001 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.120000000000005 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 49' ' ' ILE . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.439999999999998 111.01 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.542 HH21 HD11 ' A' ' 50' ' ' ILE . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.530000000000001 110.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.783 HG22 HG11 ' A' ' 42' ' ' VAL . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 60.520000000000003 111.027 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 65.120000000000005 111.128 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.319999999999993 112.449 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 121.094 0.474 . . . . 44.310000000000002 110.75 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 64.319999999999993 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 33.210000000000001 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.299999999999997 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.642 ' HE2' HD23 ' A' ' 74' ' ' LEU . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 53.420000000000002 110.94 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 45.130000000000003 111.179 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.647 HG22 ' HB2' ' A' ' 18' ' ' TYR . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 111.091 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 41' ' ' LYS . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 110.846 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 111.111 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 CA--C 1.53 0.281 0 CA-C-O 120.853 0.272 . . . . 74.209999999999994 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.530000000000001 110.825 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 6' ' ' PHE . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.169 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD23 HG13 ' A' ' 23' ' ' VAL . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.149999999999999 110.645 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG13 HD23 ' A' ' 21' ' ' LEU . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.030000000000001 111.25 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 61.32 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.209999999999994 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 60.109999999999999 111.193 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' N ' HG23 ' A' ' 27' ' ' THR . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 64.010000000000005 112.188 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.239999999999995 110.929 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.200000000000003 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 65.439999999999998 111.067 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 27' ' ' THR . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.093 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD23 HD13 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 71.409999999999997 110.965 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 44.210000000000001 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 52.219999999999999 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 111.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.310000000000002 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' VAL . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.928 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' CG ' HD13 ' A' ' 10' ' ' LEU . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 62.109999999999999 110.935 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 71.319999999999993 111.204 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 62.100000000000001 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 63.119999999999997 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.530000000000001 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.299999999999997 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.969 HG22 HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 65.010000000000005 111.058 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' ILE . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 71.510000000000005 111.181 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.420000000000002 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 65.239999999999995 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 45.25 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.200000000000003 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.510000000000005 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 63.520000000000003 111.301 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 64.140000000000001 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 65.299999999999997 112.36 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.229999999999997 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 66' ' ' VAL . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.049999999999997 111.116 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.702 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 62.149999999999999 111.171 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.430000000000007 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 70.019999999999996 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 62' ' ' THR . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 64.109999999999999 111.195 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 63.450000000000003 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 54.43 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.120000000000005 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 45.520000000000003 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 63.039999999999999 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.969 HD11 HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 52.329999999999998 110.776 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.049999999999997 110.957 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' ILE . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.016 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 50.520000000000003 111.184 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 55.020000000000003 112.201 -179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.997 0.427 . . . . 70.129999999999995 110.865 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.239999999999995 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 73.109999999999999 110.709 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 61.43 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.682 ' CG2' HD11 ' A' ' 76' ' ' ILE . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.973 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 111.256 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.192 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.234 0.292 0 CA-C-O 120.844 0.268 . . . . 74.319999999999993 112.363 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 111.051 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 64.049999999999997 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.099999999999994 111.026 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 64.25 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.329999999999998 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 6' ' ' PHE . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 65.030000000000001 111.155 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.239999999999995 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.040000000000006 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.329999999999998 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 66' ' ' VAL . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 110.735 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 111.113 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.413 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 111.263 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 29' ' ' PHE . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 111.016 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.109999999999999 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.064 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.349999999999994 111.121 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.239999999999995 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 61.509999999999998 110.906 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 61.299999999999997 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 64.120000000000005 111.165 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.140000000000001 112.398 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.119999999999997 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 44.32 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.420000000000002 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 53.200000000000003 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.814 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 72.230000000000004 111.17 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 54' ' ' GLY . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 63.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 51.030000000000001 111.113 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.120000000000005 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 62.509999999999998 112.485 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 61.009999999999998 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.310000000000002 112.716 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 56' ' ' GLY . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 64.400000000000006 111.16 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.230000000000004 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.299999999999997 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.340000000000003 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.310000000000002 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.149999999999999 111.221 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.109999999999999 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.150000000000006 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 61.530000000000001 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 111.187 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 73.239999999999995 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.150000000000006 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.319999999999993 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 55.439999999999998 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.209999999999994 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.859 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.349999999999994 110.855 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 49' ' ' ILE . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.855 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.447 ' NH2' HD11 ' A' ' 50' ' ' ILE . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.219999999999999 110.777 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.836 HG21 HG21 ' A' ' 42' ' ' VAL . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.439999999999998 110.966 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 73.239999999999995 111.339 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.049999999999997 112.306 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.742 0.306 . . . . 65.439999999999998 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.329999999999998 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 61.229999999999997 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 55.43 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD13 ' A' ' 74' ' ' LEU . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 110.818 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 70.319999999999993 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 36' ' ' ALA . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 53.020000000000003 110.93 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 40' ' ' PHE . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 72.430000000000007 110.785 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 111.141 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 CA-C-O 120.674 0.197 . . . . 72.219999999999999 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.200000000000003 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.439999999999998 110.784 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 65.109999999999999 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.299999999999997 111.023 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.879 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.400000000000006 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 27' ' ' THR . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.549999999999997 112.273 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 60.039999999999999 111.18 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.824 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 65.099999999999994 112.451 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 73.140000000000001 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 63.399999999999999 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.109999999999999 110.852 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' PRO . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 55.509999999999998 111.101 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.924 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 71.510000000000005 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 8' ' ' ILE . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.277 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.519999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.200000000000003 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.966 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.759 HG11 HG22 ' A' ' 76' ' ' ILE . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.319999999999993 111.251 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.319999999999993 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 54.030000000000001 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.400000000000006 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 61.32 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' C ' HG23 ' A' ' 76' ' ' ILE . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.140000000000001 110.941 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.741 HG22 ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.540000000000006 110.846 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.426 HD11 HD11 ' A' ' 77' ' ' ILE . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.400000000000006 111.152 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' HIS . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.420000000000002 111.167 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.230000000000004 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 70.420000000000002 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 ' CG1' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.310000000000002 111.152 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.340000000000003 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.430000000000007 112.388 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 52.420000000000002 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.67 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.409999999999997 111.268 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.530000000000001 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.099999999999994 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.439999999999998 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 62' ' ' THR . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.229999999999997 110.889 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.349999999999994 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.150000000000006 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HB3' HG22 ' A' ' 51' ' ' THR . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 63.100000000000001 110.777 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.400000000000006 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 73.230000000000004 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' CD2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.019 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.66 HH21 HD13 ' A' ' 77' ' ' ILE . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.759 HG22 HG11 ' A' ' 42' ' ' VAL . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.759 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.66 HD13 HH21 ' A' ' 75' ' ' ARG . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.120000000000005 111.169 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 71.239999999999995 112.213 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 52.119999999999997 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 5' ' ' SER . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.400000000000006 111.177 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 4' ' ' VAL . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 110.901 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 74' ' ' LEU . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.540000000000006 110.588 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 65.430000000000007 110.907 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' ILE . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 63.100000000000001 111.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 18' ' ' TYR . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.43 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.889 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.218 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 CA--C 1.522 -0.094 0 CA-C-O 120.735 0.223 . . . . 72.420000000000002 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.591 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 65.420000000000002 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 61.539999999999999 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG23 ' HG3' ' A' ' 7' ' ' LYS . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.077 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.530000000000001 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 62.240000000000002 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 43.420000000000002 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.540000000000006 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.539999999999999 110.951 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.230000000000004 111.2 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 60.340000000000003 112.595 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.701 ' CE2' HG11 ' A' ' 66' ' ' VAL . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.150000000000006 110.841 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.166 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 71.25 111.076 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 28' ' ' PRO . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.230000000000004 111.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.030000000000001 111.236 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 70.120000000000005 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.310000000000002 111.006 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.010000000000005 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' HD22 ' A' ' 10' ' ' LEU . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 63.530000000000001 111.015 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 71.040000000000006 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 71.150000000000006 111.28 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 64.230000000000004 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 64.439999999999998 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.420000000000002 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 70.129999999999995 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 51.43 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.209999999999994 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.923 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.097 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 71.319999999999993 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.299999999999997 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 42.43 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.519999999999996 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.230000000000004 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 66' ' ' VAL . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 70.150000000000006 110.971 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.519999999999996 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.219999999999999 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 70.209999999999994 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 65.109999999999999 111.077 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.010000000000005 111.01 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 53.130000000000003 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.400000000000006 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 62' ' ' THR . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.125 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 110.923 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.099999999999994 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.099999999999994 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 74' ' ' LEU . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 34.340000000000003 110.863 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 70.219999999999999 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.923 HD23 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.773 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.409999999999997 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' HB ' HG11 ' A' ' 42' ' ' VAL . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.201 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 71.519999999999996 111.244 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.130000000000003 112.26 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 72.439999999999998 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 65.310000000000002 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.540000000000006 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.019999999999996 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 76' ' ' ILE . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 111.148 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.120000000000005 111.077 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.617 HD12 ' OG1' ' A' ' 11' ' ' THR . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.737 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.617 ' OG1' HD12 ' A' ' 10' ' ' LEU . 96.9 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.539999999999999 111.067 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.906 0.294 . . . . 73.099999999999994 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.911 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 70.450000000000003 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 54.210000000000001 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 65.540000000000006 110.727 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 44.399999999999999 110.916 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 22' ' ' SER . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.349999999999994 111.219 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.66 ' O ' HG22 ' A' ' 27' ' ' THR . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.409999999999997 112.334 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 55.539999999999999 110.643 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' PRO . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.100000000000001 111.14 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.510000000000005 112.391 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.530000000000001 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 64.140000000000001 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 61.240000000000002 111.004 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 28' ' ' PRO . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 71.349999999999994 111.063 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 111.139 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 73.049999999999997 110.86 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 63.210000000000001 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.099999999999994 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 51.539999999999999 111.334 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.530000000000001 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 21' ' ' LEU . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.755 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 71.540000000000006 110.901 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 72.519999999999996 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.329999999999998 111.102 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 32.43 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.439999999999998 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.299999999999997 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 77' ' ' ILE . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 111.111 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' HG ' ' A' ' 33' ' ' LEU . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.085 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.319999999999993 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 52.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.340000000000003 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 63.009999999999998 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.540000000000006 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 64.340000000000003 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 61.340000000000003 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.085 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 110.927 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 54.439999999999998 112.399 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.299999999999997 111.356 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 25' ' ' GLU . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 111.218 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.230000000000004 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 62.439999999999998 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 62' ' ' THR . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 60.310000000000002 111.212 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 64.209999999999994 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 74.200000000000003 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.603 ' HB3' HG21 ' A' ' 51' ' ' THR . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 73.030000000000001 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.329999999999998 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 71.319999999999993 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.219999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 8' ' ' ILE . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.230000000000004 111.176 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 48' ' ' ALA . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 65.239999999999995 111.286 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.386 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.496 0.498 . . . . 45.030000000000001 112.814 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.4 120.84 7.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.673 2.249 . . . . 45.119999999999997 112.275 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mt -137.84 145.56 42.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.992 -0.549 . . . . 63.229999999999997 110.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.04 104.28 0.19 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.531 -0.842 . . . . 73.109999999999999 112.395 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.2 m -151.26 173.31 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 71.120000000000005 110.979 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp -178.76 -36.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.259 -0.428 . . . . 72.409999999999997 110.833 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -151.03 126.35 10.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.459 . . . . 53.530000000000001 110.686 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.340000000000003 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.310000000000002 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.039999999999999 111.014 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 64.030000000000001 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 21' ' ' LEU . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 73.329999999999998 111.211 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.129999999999995 111.149 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.817 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.03 -35.39 2.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 71.420000000000002 111.17 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.73 30.13 6.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 55.229999999999997 110.819 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.15 160.48 65.51 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.699 0.761 . . . . 72.430000000000007 110.859 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.61 -31.89 20.3 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.793 2.329 . . . . 51.299999999999997 112.273 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -70.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 74.200000000000003 110.835 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.33 160.67 31.39 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 121.503 0.668 . . . . 75.519999999999996 111.161 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.97 -170.93 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.578 2.185 . . . . 73.019999999999996 112.111 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.150000000000006 110.907 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 72.319999999999993 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 71.030000000000001 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 62.240000000000002 110.919 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 60.450000000000003 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.409999999999997 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.329999999999998 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 63.329999999999998 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.310000000000002 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' HG11 ' A' ' 66' ' ' VAL . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 72.219999999999999 111.082 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 55.5 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.230000000000004 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' PRO . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.07 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 49' ' ' ILE . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 53.420000000000002 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.083 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.519999999999996 110.864 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.319999999999993 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.340000000000003 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' A' ' 10' ' ' LEU . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.219999999999999 111.05 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 64.430000000000007 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.552 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 74.450000000000003 110.921 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 76' ' ' ILE . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 55.030000000000001 112.643 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 53.310000000000002 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 72.109999999999999 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 63.229999999999997 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.209999999999994 111.061 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.040000000000006 111.083 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 70' ' ' HIS . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.010000000000005 111.125 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.540000000000006 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 44.299999999999997 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 72.120000000000005 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.599 HD13 ' CD2' ' A' ' 70' ' ' HIS . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.230000000000004 110.83 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.340000000000003 112.379 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 55.020000000000003 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.150000000000006 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 53.219999999999999 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 72.049999999999997 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.219999999999999 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.200000000000003 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG11 ' CE2' ' A' ' 29' ' ' PHE . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 72.349999999999994 111.178 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.129999999999995 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 63.119999999999997 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 57' ' ' ILE . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 71.239999999999995 110.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.310000000000002 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.219999999999999 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 65.040000000000006 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 54.130000000000003 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 77' ' ' ILE . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.209999999999994 111.281 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.129999999999995 111.137 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.1 144.63 52.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.439999999999998 112.217 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -100.41 -31.19 11.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.391 . . . . 73.239999999999995 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 173.75 12.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 64.200000000000003 110.847 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.99 151.75 33.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 110.856 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.16 -42.63 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.154 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 64.109999999999999 112.509 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.281 0.378 . . . . 74.140000000000001 112.739 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.68 28.52 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.531 2.154 . . . . 64.319999999999993 112.419 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -126.83 163.46 23.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.942 0.401 . . . . 70.109999999999999 110.85 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 130.92 -164.63 23.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.876 -0.678 . . . . 54.109999999999999 112.509 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.7 m -95.27 -60.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.459 . . . . 71.420000000000002 110.997 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm -173.77 58.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.846 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -172.86 125.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 64.430000000000007 111.0 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 62.140000000000001 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.442 HG21 ' HA2' ' A' ' 64' ' ' GLY . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 64.319999999999993 111.146 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 8' ' ' ILE . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.120000000000005 110.793 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 73.319999999999993 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.582 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.400000000000006 110.79 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 111.127 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 52.109999999999999 111.146 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER 179.78 -30.88 0.01 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.039999999999999 111.109 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t 68.78 9.98 7.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.037 0.446 . . . . 72.340000000000003 110.921 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.74 161.9 0.11 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 72.400000000000006 110.924 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 -14.29 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.854 2.369 . . . . 65.510000000000005 112.289 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -158.81 -41.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.96 0.41 . . . . 72.010000000000005 110.98 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -56.86 162.63 3.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 60.530000000000001 110.937 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.63 167.57 23.9 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.678 2.252 . . . . 72.030000000000001 112.548 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.735 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.003 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 71.340000000000003 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.430000000000007 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.230000000000004 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 24' ' ' PRO . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.420000000000002 110.933 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 23' ' ' VAL . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.219999999999999 112.4 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.030000000000001 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.239999999999995 112.548 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.340000000000003 110.631 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 54.109999999999999 111.145 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.229999999999997 110.844 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' PRO . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.340000000000003 111.108 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 63.119999999999997 110.984 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 54.329999999999998 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.409999999999997 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.078 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.349999999999994 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 60.520000000000003 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' HB3' HD22 ' A' ' 10' ' ' LEU . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 53.219999999999999 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 63.539999999999999 111.367 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.430000000000007 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 54.210000000000001 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.129999999999995 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.439999999999998 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 63.530000000000001 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.735 HD13 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 41.340000000000003 111.01 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA2' ' A' ' 54' ' ' GLY . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 61.520000000000003 111.162 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 72.409999999999997 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.099999999999994 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.100000000000001 112.523 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.349999999999994 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.230000000000004 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 HG12 ' A' ' 66' ' ' VAL . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.329999999999998 111.175 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.129999999999995 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.239999999999995 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 52.530000000000001 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.941 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 62.310000000000002 110.988 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.743 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 63.5 111.075 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 4' ' ' VAL . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.209999999999994 112.371 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.329999999999998 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 62' ' ' THR . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 63.43 111.349 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 54.439999999999998 111.049 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.120000000000005 110.825 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 61.520000000000003 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.409999999999997 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.450000000000003 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 8' ' ' ILE . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.319999999999993 110.955 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 73.040000000000006 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 53.43 111.37 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.120000000000005 110.949 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.51 133.14 25.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 52.420000000000002 112.515 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.67 174.0 8.28 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.054 -0.521 . . . . 75.120000000000005 110.899 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 t0 57.93 -176.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 75.310000000000002 110.87 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -44.56 7.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 73.439999999999998 110.961 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.99 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 72.209999999999994 110.983 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.943 -0.646 . . . . 53.100000000000001 112.474 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-O 121.318 0.399 . . . . 53.219999999999999 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.97 -171.3 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.581 2.188 . . . . 62.229999999999997 112.186 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.73 167.7 6.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 75.409999999999997 111.017 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -131.21 143.61 15.07 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.925 -0.655 . . . . 52.119999999999997 112.583 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.88 141.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.879 0.371 . . . . 54.340000000000003 110.787 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt -62.37 -62.7 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.5 110.767 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.66 136.33 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 70.519999999999996 110.615 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.439999999999998 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 64.200000000000003 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.319999999999993 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.897 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 6' ' ' PHE . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 71.340000000000003 111.235 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 18' ' ' TYR . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 53.399999999999999 111.395 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 64.239999999999995 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.89 -40.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 54.340000000000003 111.246 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.1 31.03 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 64.329999999999998 110.815 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.13 161.18 0.76 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.568 0.699 . . . . 74.439999999999998 110.832 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -33.61 15.95 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.696 2.264 . . . . 70.040000000000006 112.186 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -55.91 -70.15 0.12 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.174 -0.467 . . . . 73.129999999999995 110.811 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.49 160.4 26.37 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.6 0.714 . . . . 71.230000000000004 110.886 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.86 -178.16 2.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 73.400000000000006 112.303 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.784 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 73.409999999999997 110.805 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 54.039999999999999 111.264 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 111.047 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.200000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' HD2' ' A' ' 24' ' ' PRO . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 44.0 110.883 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 23' ' ' VAL . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.439999999999998 112.342 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 70.340000000000003 111.168 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.109999999999999 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.648 ' CE1' HG11 ' A' ' 66' ' ' VAL . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.129999999999995 110.802 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 111.108 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.913 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 44.420000000000002 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 43.549999999999997 110.97 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 42.299999999999997 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 110.992 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.099999999999994 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' ALA . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.932 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 60.229999999999997 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG11 ' CG2' ' A' ' 76' ' ' ILE . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.310000000000002 111.178 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.409999999999997 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.310000000000002 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.030000000000001 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.439999999999998 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.129999999999995 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.688 HD12 HD11 ' A' ' 33' ' ' LEU . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.340000000000003 110.908 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.649 HD12 ' HA2' ' A' ' 54' ' ' GLY . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 64.019999999999996 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 71.540000000000006 111.141 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.030000000000001 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 44.549999999999997 112.515 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 64.200000000000003 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 52.219999999999999 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.450000000000003 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.310000000000002 110.811 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.439999999999998 112.311 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 43.420000000000002 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 44.409999999999997 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.586 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.329999999999998 111.206 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 23.140000000000001 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.520000000000003 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.648 HG11 ' CE1' ' A' ' 29' ' ' PHE . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.549999999999997 111.064 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 71.219999999999999 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.519999999999996 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 64.239999999999995 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.540000000000006 110.769 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.430000000000007 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.658 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.409999999999997 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.200000000000003 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' SER . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.893 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.71 ' CG2' HG11 ' A' ' 42' ' ' VAL . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 70.239999999999995 111.191 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 50' ' ' ILE . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 74.439999999999998 111.32 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 131.32 20.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 33.530000000000001 112.309 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.13 143.76 45.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 54.030000000000001 110.867 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 62.0 179.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 60.020000000000003 110.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -130.99 175.18 9.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 110.758 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.87 169.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 111.146 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.614 -0.803 . . . . 75.340000000000003 112.416 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.491 0.495 . . . . 74.120000000000005 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.75 157.28 60.96 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.581 2.187 . . . . 71.230000000000004 112.414 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 21.0 mt -119.12 68.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 71.510000000000005 110.806 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.84 -147.51 15.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 73.439999999999998 112.576 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -143.47 82.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.01 0.434 . . . . 32.509999999999998 110.824 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -60.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 72.530000000000001 110.998 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -179.36 149.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 63.340000000000003 111.044 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 70.209999999999994 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.400000000000006 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.129999999999995 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.329999999999998 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 18' ' ' TYR . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.843 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.340000000000003 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 13' ' ' ASP . 14.0 t -175.82 -34.81 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 74.25 111.047 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p 49.49 50.19 18.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.779 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' HD13 ' A' ' 16' ' ' LEU . 17.6 p-10 -51.56 153.62 3.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.572 0.701 . . . . 62.340000000000003 110.981 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.73 149.25 66.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.729 2.286 . . . . 74.25 112.346 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.602 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER 53.53 44.79 29.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 70.420000000000002 110.609 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -163.31 160.24 18.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.326 0.584 . . . . 62.340000000000003 111.005 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' HD23 ' A' ' 16' ' ' LEU . 54.9 Cg_endo -69.54 -170.8 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.632 2.222 . . . . 61.200000000000003 112.322 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.409999999999997 111.017 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.439999999999998 111.16 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 20' ' ' VAL . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 62.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.319999999999993 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 62.399999999999999 111.408 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.520000000000003 112.34 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.549999999999997 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.319999999999993 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.200000000000003 111.236 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.329999999999998 112.585 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.030000000000001 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.042 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 27' ' ' THR . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.030000000000001 111.18 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.120000000000005 110.935 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.540000000000006 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.229999999999997 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 110.965 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.219999999999999 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 70.310000000000002 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 63.420000000000002 111.354 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.66 ' O ' HD11 ' A' ' 76' ' ' ILE . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 61.399999999999999 112.068 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 54.420000000000002 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.340000000000003 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.420000000000002 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.520000000000003 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.510000000000005 111.12 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA2' ' A' ' 54' ' ' GLY . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 64.219999999999999 111.191 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.539999999999999 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.129999999999995 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.676 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.420000000000002 112.445 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.219999999999999 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 72.120000000000005 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 HG12 ' A' ' 66' ' ' VAL . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.310000000000002 111.05 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.519999999999996 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.129999999999995 112.297 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.150000000000006 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 64.239999999999995 111.004 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.129999999999995 110.947 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 34.229999999999997 110.971 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.319999999999993 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 71.319999999999993 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 70.430000000000007 111.111 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.210000000000001 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.120000000000005 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 53.43 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.430000000000007 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.130000000000003 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.439999999999998 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.219999999999999 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.58 ' NH1' HD11 ' A' ' 50' ' ' ILE . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.89 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 43' ' ' PRO . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 71.349999999999994 111.389 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ILE . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 70.319999999999993 111.331 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.06 146.43 58.33 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.140000000000001 112.144 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -91.86 -35.12 14.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 73.150000000000006 110.872 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.22 90.49 0.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.122 -0.49 . . . . 74.340000000000003 111.002 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.28 -62.09 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.445 -0.343 . . . . 73.230000000000004 111.112 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -57.07 174.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 72.010000000000005 111.234 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 C-N-CA 120.583 -0.818 . . . . 54.450000000000003 112.537 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 121.359 0.422 . . . . 75.310000000000002 112.636 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.09 -174.18 0.92 Allowed 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 2.274 . . . . 74.209999999999994 112.282 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.64 79.9 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 110.926 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -62.53 155.57 40.45 Favored Glycine 0 C--O 1.229 -0.187 0 C-N-CA 120.653 -0.784 . . . . 73.120000000000005 112.534 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.2 m -163.08 63.62 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 70.439999999999998 110.936 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt -117.41 -57.14 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.861 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -163.65 69.28 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 71.439999999999998 110.436 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 65.549999999999997 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 67' ' ' PHE . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.299999999999997 111.255 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.129999999999995 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.86 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 76' ' ' ILE . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.109999999999999 111.088 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.027 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.430000000000007 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.12 -37.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t 51.14 52.4 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.420000000000002 110.867 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.82 160.55 0.78 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.515 0.674 . . . . 74.319999999999993 110.854 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -44.07 2.26 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.561 2.174 . . . . 62.43 112.329 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -75.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.982 0.42 . . . . 74.019999999999996 110.903 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.64 160.6 36.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.557 0.694 . . . . 70.209999999999994 110.928 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.03 -170.78 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.699 2.266 . . . . 74.129999999999995 112.146 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.71 ' HB2' HG22 ' A' ' 9' ' ' THR . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.040000000000006 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.219999999999999 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 6' ' ' PHE . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.319999999999993 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 72.519999999999996 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 71.510000000000005 111.129 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.358 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.140000000000001 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.140000000000001 111.116 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 45.009999999999998 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.726 ' CE1' HG11 ' A' ' 66' ' ' VAL . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 61.399999999999999 110.813 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.420000000000002 111.186 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.150000000000006 111.086 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 44.049999999999997 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 HG13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 61.130000000000003 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.210000000000001 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 76' ' ' ILE . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 32.219999999999999 110.939 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.149999999999999 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 74.530000000000001 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.783 HG11 HG22 ' A' ' 76' ' ' ILE . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 63.109999999999999 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.209999999999994 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.140000000000001 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.540000000000006 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.319999999999993 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 79' ' ' ARG . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 64.510000000000005 111.137 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.655 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.239999999999995 110.886 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' HA2' ' A' ' 54' ' ' GLY . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 62.43 111.111 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 55' ' ' ILE . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.140000000000001 111.215 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.420000000000002 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 53.130000000000003 112.384 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.75 HG22 ' OG1' ' A' ' 51' ' ' THR . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.450000000000003 111.094 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 65.439999999999998 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 HD11 ' CG2' ' A' ' 51' ' ' THR . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 70.310000000000002 111.268 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.409999999999997 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.409999999999997 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 52.43 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 72.150000000000006 111.154 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.256 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.120000000000005 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.239999999999995 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.726 HG11 ' CE1' ' A' ' 29' ' ' PHE . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 72.140000000000001 111.151 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 4' ' ' VAL . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.409999999999997 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 71.109999999999999 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.010000000000005 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.140000000000001 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.120000000000005 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 49' ' ' ILE . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.439999999999998 111.01 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 HH21 HD11 ' A' ' 50' ' ' ILE . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.530000000000001 110.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.783 HG22 HG11 ' A' ' 42' ' ' VAL . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 60.520000000000003 111.027 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 65.120000000000005 111.128 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 118.32 5.61 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.319999999999993 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 9.6 tmm_? -63.44 -37.42 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 73.109999999999999 110.843 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.09 33.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 74.540000000000006 110.762 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.22 -174.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 110.843 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.43 144.61 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 64.230000000000004 111.115 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 C-N-CA 120.765 -0.731 . . . . 72.510000000000005 112.474 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 CA-C-O 121.332 0.407 . . . . 54.039999999999999 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 -46.53 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.597 2.198 . . . . 71.239999999999995 112.31 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.46 175.01 8.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 110.879 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 65.22 57.74 11.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 73.120000000000005 112.746 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.5 132.4 31.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.026 0.441 . . . . 65.109999999999999 110.739 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm -95.74 88.76 5.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 73.310000000000002 110.776 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.03 152.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.094 0.474 . . . . 44.310000000000002 110.75 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 64.319999999999993 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 33.210000000000001 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.299999999999997 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.642 ' HE2' HD23 ' A' ' 74' ' ' LEU . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 53.420000000000002 110.94 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 45.130000000000003 111.179 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.647 HG22 ' HB2' ' A' ' 18' ' ' TYR . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 111.091 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 41' ' ' LYS . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 110.846 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.44 -40.11 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 111.111 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.16 29.39 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 71.109999999999999 110.853 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.75 160.6 43.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.75 0.786 . . . . 74.239999999999995 110.811 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.59 28.46 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.66 2.24 . . . . 53.43 112.413 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -61.44 -67.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 64.420000000000002 110.844 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -101.43 160.29 26.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 121.607 0.718 . . . . 75.329999999999998 110.832 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HD2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_endo -69.63 -179.86 3.14 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.698 2.265 . . . . 74.209999999999994 112.228 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.530000000000001 110.825 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 6' ' ' PHE . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.169 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD23 HG13 ' A' ' 23' ' ' VAL . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.149999999999999 110.645 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG13 HD23 ' A' ' 21' ' ' LEU . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.030000000000001 111.25 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 61.32 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.209999999999994 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 60.109999999999999 111.193 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' N ' HG23 ' A' ' 27' ' ' THR . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 64.010000000000005 112.188 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.239999999999995 110.929 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.200000000000003 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 65.439999999999998 111.067 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 27' ' ' THR . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.093 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD23 HD13 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 71.409999999999997 110.965 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 44.210000000000001 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.409999999999997 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 52.219999999999999 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 111.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.310000000000002 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' VAL . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.928 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' CG ' HD13 ' A' ' 10' ' ' LEU . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 62.109999999999999 110.935 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 71.319999999999993 111.204 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 62.100000000000001 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 63.119999999999997 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.030000000000001 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.530000000000001 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.299999999999997 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.969 HG22 HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 65.010000000000005 111.058 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' ILE . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 71.510000000000005 111.181 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.420000000000002 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 65.239999999999995 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 45.25 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.200000000000003 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.510000000000005 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 63.520000000000003 111.301 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 64.140000000000001 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 65.299999999999997 112.36 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.229999999999997 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 66' ' ' VAL . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.049999999999997 111.116 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.702 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 62.149999999999999 111.171 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.430000000000007 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 70.019999999999996 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 62' ' ' THR . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 64.109999999999999 111.195 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 63.450000000000003 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 54.43 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.120000000000005 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 45.520000000000003 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 63.039999999999999 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.969 HD11 HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 52.329999999999998 110.776 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.049999999999997 110.957 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' ILE . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.016 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 50.520000000000003 111.184 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 148.01 63.83 Favored 'Trans proline' 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 55.020000000000003 112.201 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 171.58 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.985 -0.552 . . . . 64.409999999999997 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.5 -172.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.030000000000001 110.943 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -116.7 90.35 3.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.329 -0.396 . . . . 73.540000000000006 110.886 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.82 167.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.01 -0.541 . . . . 64.540000000000006 110.939 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 C-N-CA 120.462 -0.875 . . . . 64.540000000000006 112.499 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.632 0.573 . . . . 74.109999999999999 112.76 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.7 145.73 58.36 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.744 2.296 . . . . 74.030000000000001 112.174 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 72.340000000000003 111.165 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 153.56 87.09 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.83 -0.7 . . . . 45.509999999999998 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.52 175.87 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.786 0.327 . . . . 72.129999999999995 110.91 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt -110.08 -54.73 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.86 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -90.61 112.69 24.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 70.129999999999995 110.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.239999999999995 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 73.109999999999999 110.709 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 61.43 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.682 ' CG2' HD11 ' A' ' 76' ' ' ILE . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.973 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 51.030000000000001 111.256 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.77 -35.18 2.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.192 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.83 29.27 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 75.510000000000005 110.797 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.77 160.55 43.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.241 0.544 . . . . 75.150000000000006 110.955 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -31.45 20.55 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.632 2.222 . . . . 52.340000000000003 112.462 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -52.11 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 60.43 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.66 160.63 25.49 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.665 0.745 . . . . 72.400000000000006 110.865 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.59 10.74 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.618 2.212 . . . . 74.319999999999993 112.363 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.340000000000003 111.051 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 64.049999999999997 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.099999999999994 111.026 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 64.25 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.329999999999998 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 6' ' ' PHE . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 65.030000000000001 111.155 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.239999999999995 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.409999999999997 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.040000000000006 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.329999999999998 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 66' ' ' VAL . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 110.735 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 111.113 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.413 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 111.263 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 29' ' ' PHE . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 64.329999999999998 111.016 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.299999999999997 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.109999999999999 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 111.064 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.349999999999994 111.121 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.239999999999995 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 61.509999999999998 110.906 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 61.299999999999997 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 64.120000000000005 111.165 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.140000000000001 112.398 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.119999999999997 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 44.32 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.420000000000002 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 53.200000000000003 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.814 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 72.230000000000004 111.17 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 54' ' ' GLY . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 63.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 51.030000000000001 111.113 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.120000000000005 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 62.509999999999998 112.485 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 61.009999999999998 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.310000000000002 112.716 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 56' ' ' GLY . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 64.400000000000006 111.16 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.230000000000004 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.299999999999997 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.340000000000003 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.310000000000002 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.149999999999999 111.221 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.109999999999999 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.150000000000006 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 61.530000000000001 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 111.187 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 73.239999999999995 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.150000000000006 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.319999999999993 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 55.439999999999998 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.209999999999994 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.859 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.349999999999994 110.855 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 49' ' ' ILE . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.120000000000005 110.855 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' NH2' HD11 ' A' ' 50' ' ' ILE . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.219999999999999 110.777 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.836 HG21 HG21 ' A' ' 42' ' ' VAL . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.439999999999998 110.966 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 73.239999999999995 111.339 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.51 1.87 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.049999999999997 112.306 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -52.13 -47.17 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.030000000000001 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.39 26.66 1.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.997 -0.547 . . . . 55.149999999999999 110.873 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 51.88 84.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 111.093 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.94 146.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 74.340000000000003 111.266 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.756 . . . . 61.109999999999999 112.618 -179.852 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.081 0 CA-C-O 121.516 0.509 . . . . 52.530000000000001 112.363 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -178.72 2.44 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.775 2.317 . . . . 74.400000000000006 112.286 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 13.2 tp -120.52 -45.67 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 73.319999999999993 111.01 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.71 -47.25 4.3 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.759 -0.734 . . . . 62.340000000000003 112.425 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.2 m 63.1 34.39 13.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 71.030000000000001 110.885 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -113.6 57.88 0.68 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 111.554 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -163.41 73.52 0.32 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.807 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.329999999999998 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 61.229999999999997 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 55.43 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD13 ' A' ' 74' ' ' LEU . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 110.818 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 70.319999999999993 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 36' ' ' ALA . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 53.020000000000003 110.93 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 40' ' ' PHE . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 72.430000000000007 110.785 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 9.66 2.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 111.141 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.06 16.29 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 63.299999999999997 110.846 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 61.4 162.7 0.11 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.310000000000002 110.741 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.97 -48.71 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.977 2.451 . . . . 73.409999999999997 112.293 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 16' ' ' LEU . 15.2 mtt180 -130.35 65.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 72.319999999999993 110.966 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.618 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -170.15 160.39 6.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.63 0.729 . . . . 53.049999999999997 110.971 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.618 ' HD2' HD23 ' A' ' 16' ' ' LEU . 52.0 Cg_endo -69.9 -53.15 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.692 2.262 . . . . 72.219999999999999 112.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.200000000000003 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.439999999999998 110.784 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 65.109999999999999 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.299999999999997 111.023 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.239999999999995 110.879 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.400000000000006 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 27' ' ' THR . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.549999999999997 112.273 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.099999999999994 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 60.039999999999999 111.18 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.824 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 65.099999999999994 112.451 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 73.140000000000001 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 63.399999999999999 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.109999999999999 110.852 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' PRO . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 55.509999999999998 111.101 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.924 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 71.510000000000005 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 8' ' ' ILE . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.329999999999998 111.277 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.519999999999996 111.147 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.200000000000003 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.430000000000007 110.966 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.759 HG11 HG22 ' A' ' 76' ' ' ILE . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.319999999999993 111.251 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.319999999999993 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 54.030000000000001 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.400000000000006 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 61.32 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.439999999999998 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' C ' HG23 ' A' ' 76' ' ' ILE . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.140000000000001 110.941 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.741 HG22 ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.540000000000006 110.846 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.426 HD11 HD11 ' A' ' 77' ' ' ILE . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.400000000000006 111.152 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' HIS . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.420000000000002 111.167 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.230000000000004 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 70.420000000000002 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 ' CG1' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.310000000000002 111.152 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.340000000000003 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.430000000000007 112.388 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 52.420000000000002 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.67 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.409999999999997 111.268 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.530000000000001 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.099999999999994 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.439999999999998 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 62' ' ' THR . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.229999999999997 110.889 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.209999999999994 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.349999999999994 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.150000000000006 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HB3' HG22 ' A' ' 51' ' ' THR . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 63.100000000000001 110.777 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.400000000000006 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.120000000000005 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 73.230000000000004 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' CD2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.099999999999994 111.019 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.66 HH21 HD13 ' A' ' 77' ' ' ILE . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.759 HG22 HG11 ' A' ' 42' ' ' VAL . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.759 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.66 HD13 HH21 ' A' ' 75' ' ' ARG . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.120000000000005 111.169 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 130.84 19.89 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 71.239999999999995 112.213 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -35.66 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 70.450000000000003 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -119.59 146.04 45.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.336 -0.393 . . . . 73.310000000000002 110.917 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 57.9 87.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 75.230000000000004 111.029 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 m -114.65 158.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 74.219999999999999 110.983 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.291 0 C-N-CA 120.649 -0.786 . . . . 71.530000000000001 112.489 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 CA-C-O 121.353 0.418 . . . . 50.43 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 141.98 46.4 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.845 2.364 . . . . 71.450000000000003 112.221 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.1 124.74 42.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 54.43 110.887 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -109.13 100.66 1.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 74.420000000000002 112.332 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.31 138.85 21.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.844 0.354 . . . . 44.329999999999998 110.914 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.98 -57.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 74.349999999999994 110.88 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -125.39 142.34 51.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 52.119999999999997 111.053 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 5' ' ' SER . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.400000000000006 111.177 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 4' ' ' VAL . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 110.901 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 74' ' ' LEU . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.540000000000006 110.588 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 65.430000000000007 110.907 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' ILE . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 63.100000000000001 111.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 18' ' ' TYR . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.43 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 110.889 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -162.07 -35.66 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.218 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.74 7.27 6.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 74.239999999999995 110.811 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.13 162.63 0.1 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.647 0.737 . . . . 74.219999999999999 110.734 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.9 -9.45 26.09 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.871 2.381 . . . . 71.25 112.177 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -163.72 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 75.140000000000001 110.822 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -53.91 162.67 1.35 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.495 0.664 . . . . 63.240000000000002 111.026 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 16' ' ' LEU . 54.6 Cg_endo -69.48 169.76 17.81 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.649 2.232 . . . . 72.420000000000002 112.543 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.591 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 65.420000000000002 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 61.539999999999999 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG23 ' HG3' ' A' ' 7' ' ' LYS . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.077 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.530000000000001 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 62.240000000000002 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 43.420000000000002 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.540000000000006 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.539999999999999 110.951 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.230000000000004 111.2 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 60.340000000000003 112.595 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.701 ' CE2' HG11 ' A' ' 66' ' ' VAL . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.150000000000006 110.841 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.166 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 71.25 111.076 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 28' ' ' PRO . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.230000000000004 111.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.030000000000001 111.236 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 70.120000000000005 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.310000000000002 111.006 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.010000000000005 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.109999999999999 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' HD22 ' A' ' 10' ' ' LEU . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 63.530000000000001 111.015 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 71.040000000000006 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 71.150000000000006 111.28 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 64.230000000000004 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 64.439999999999998 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.420000000000002 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 70.129999999999995 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 51.43 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.209999999999994 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.923 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.430000000000007 111.097 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 71.319999999999993 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.299999999999997 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.209999999999994 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 42.43 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.519999999999996 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.230000000000004 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 66' ' ' VAL . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 70.150000000000006 110.971 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.519999999999996 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.219999999999999 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 70.209999999999994 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 65.109999999999999 111.077 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.010000000000005 111.01 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 53.130000000000003 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.400000000000006 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 62' ' ' THR . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.125 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 110.923 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.340000000000003 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.099999999999994 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.099999999999994 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 74' ' ' LEU . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 34.340000000000003 110.863 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 70.219999999999999 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.923 HD23 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.773 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.409999999999997 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' HB ' HG11 ' A' ' 42' ' ' VAL . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.201 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 71.519999999999996 111.244 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.0 150.01 66.13 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.130000000000003 112.26 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -38.2 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 75.049999999999997 110.932 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.93 143.98 28.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.868 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 -174.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.409999999999997 110.885 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.22 103.48 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.488 . . . . 54.420000000000002 111.165 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.746 -0.74 . . . . 65.340000000000003 112.618 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' -2' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 121.402 0.445 . . . . 50.409999999999997 112.585 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 80.76 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.762 2.308 . . . . 72.049999999999997 112.236 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' -4' ' ' GLY . 0.8 OUTLIER -83.8 176.2 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 60.520000000000003 110.896 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 164.8 140.39 2.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 74.109999999999999 112.465 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.7 p -104.76 93.43 4.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 55.329999999999998 110.804 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.14 -70.68 0.27 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.101 -0.5 . . . . 70.409999999999997 110.914 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -120.93 31.5 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 72.219999999999999 110.875 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 72.439999999999998 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 65.310000000000002 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.540000000000006 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.019999999999996 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 76' ' ' ILE . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 111.148 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.120000000000005 111.077 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.617 HD12 ' OG1' ' A' ' 11' ' ' THR . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.737 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.617 ' OG1' HD12 ' A' ' 10' ' ' LEU . 96.9 m -117.57 -24.58 7.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.539999999999999 111.067 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.1 8.23 6.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.942 0.401 . . . . 54.32 110.723 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.11 59.13 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.419 0.628 . . . . 73.420000000000002 110.667 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.71 -26.27 27.97 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.666 2.244 . . . . 75.439999999999998 112.21 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.33 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 73.430000000000007 110.902 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -177.56 -61.79 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 40.210000000000001 110.97 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 16' ' ' LEU . 53.5 Cg_endo -69.77 -167.72 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.555 2.17 . . . . 73.099999999999994 112.329 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.911 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 70.450000000000003 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 54.210000000000001 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 65.540000000000006 110.727 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 44.399999999999999 110.916 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 22' ' ' SER . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.349999999999994 111.219 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.66 ' O ' HG22 ' A' ' 27' ' ' THR . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.409999999999997 112.334 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 55.539999999999999 110.643 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.310000000000002 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' PRO . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.100000000000001 111.14 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.510000000000005 112.391 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.530000000000001 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 64.140000000000001 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 61.240000000000002 111.004 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 28' ' ' PRO . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 71.349999999999994 111.063 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.340000000000003 111.139 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 73.049999999999997 110.86 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 63.210000000000001 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.099999999999994 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 51.539999999999999 111.334 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.530000000000001 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 21' ' ' LEU . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 72.439999999999998 110.755 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 71.540000000000006 110.901 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 72.519999999999996 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.329999999999998 111.102 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 32.43 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.439999999999998 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.299999999999997 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 77' ' ' ILE . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 111.111 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' HG ' ' A' ' 33' ' ' LEU . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.319999999999993 111.085 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.319999999999993 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 52.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.340000000000003 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 63.009999999999998 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.540000000000006 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 64.340000000000003 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 61.340000000000003 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.085 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 110.927 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 54.439999999999998 112.399 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.299999999999997 111.356 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 25' ' ' GLU . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 111.218 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.230000000000004 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 62.439999999999998 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 62' ' ' THR . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 60.310000000000002 111.212 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 64.209999999999994 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 74.200000000000003 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.603 ' HB3' HG21 ' A' ' 51' ' ' THR . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 73.030000000000001 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.329999999999998 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.329999999999998 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 71.319999999999993 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.219999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 8' ' ' ILE . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.230000000000004 111.176 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 48' ' ' ALA . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 65.239999999999995 111.286 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.6 88.81 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.386 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -75.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -169.15 61.88 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 75.540000000000006 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.63 129.8 55.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 110.865 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.06 153.99 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.074 0.464 . . . . 74.209999999999994 110.99 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 45.409999999999997 112.532 179.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.063 0.459 . . . . 53.53 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.41 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.34 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.31 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.04 111.014 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 64.03 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 21' ' ' LEU . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.211 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.13 111.149 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.817 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 71.42 111.17 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.858 0.274 . . . . 73.02 112.111 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.15 110.907 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 72.32 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 71.03 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 62.24 110.919 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 60.45 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.41 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.33 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 63.33 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.31 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' HG11 ' A' ' 66' ' ' VAL . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 72.22 111.082 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 55.5 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.23 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' PRO . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.07 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 49' ' ' ILE . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.14 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 53.42 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.14 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.11 111.083 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.52 110.864 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.32 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.34 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' A' ' 10' ' ' LEU . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.22 111.05 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 64.43 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.552 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 74.45 110.921 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 76' ' ' ILE . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 55.03 112.643 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 53.31 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 72.11 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.2 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 63.23 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.21 111.061 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.04 111.083 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 70' ' ' HIS . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.01 111.125 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.54 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 44.3 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 72.12 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.599 HD13 ' CD2' ' A' ' 70' ' ' HIS . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.23 110.83 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.34 112.379 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 55.02 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.15 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 53.22 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 72.05 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.22 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.2 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG11 ' CE2' ' A' ' 29' ' ' PHE . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 72.35 111.178 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.13 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 63.12 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 57' ' ' ILE . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 71.24 110.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.31 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.22 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 65.04 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 54.13 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.11 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 77' ' ' ILE . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.21 111.281 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.13 111.137 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.44 112.217 -179.797 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.985 0.421 . . . . 64.43 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 62.14 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.442 HG21 ' HA2' ' A' ' 64' ' ' GLY . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 64.32 111.146 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.42 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 8' ' ' ILE . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.12 110.793 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.582 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.4 110.79 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.12 111.127 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 52.11 111.146 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.04 111.109 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.233 0.238 0 CA-C-O 120.77 0.238 . . . . 72.03 112.548 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.735 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.003 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 71.34 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.43 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.23 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 24' ' ' PRO . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.42 110.933 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 23' ' ' VAL . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.22 112.4 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.03 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.34 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.24 112.548 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.631 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.145 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.23 110.844 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' PRO . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.34 111.108 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 63.12 110.984 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 54.33 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.41 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.078 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.35 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 60.52 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' HB3' HD22 ' A' ' 10' ' ' LEU . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.11 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 53.22 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 63.54 111.367 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.43 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 54.21 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.13 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.44 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 63.53 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.735 HD13 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 41.34 111.01 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA2' ' A' ' 54' ' ' GLY . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 61.52 111.162 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 72.41 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.1 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.44 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.1 112.523 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.35 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.23 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 HG12 ' A' ' 66' ' ' VAL . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.33 111.175 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.13 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.24 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 52.53 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 62.31 110.988 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.743 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 63.5 111.075 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 4' ' ' VAL . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.371 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.33 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 62' ' ' THR . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 63.43 111.349 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.049 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.12 110.825 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.21 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 61.52 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.41 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.45 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 8' ' ' ILE . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.32 110.955 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 73.04 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 53.43 111.37 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.12 110.949 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 52.42 112.515 179.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 121.193 0.52 . . . . 70.52 110.615 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.44 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 64.2 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.32 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.897 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 6' ' ' PHE . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.235 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 18' ' ' TYR . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 53.4 111.395 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 64.24 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 54.34 111.246 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.623 0.176 . . . . 73.4 112.303 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.784 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 73.41 110.805 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.12 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 54.04 111.264 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 73.2 111.047 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.2 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' HD2' ' A' ' 24' ' ' PRO . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 44.0 110.883 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 23' ' ' VAL . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.44 112.342 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 70.34 111.168 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.11 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.648 ' CE1' HG11 ' A' ' 66' ' ' VAL . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.802 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.108 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.913 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 44.42 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 43.55 110.97 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 42.3 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.11 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.992 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.1 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.04 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' ALA . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.932 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 60.23 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.71 HG11 ' CG2' ' A' ' 76' ' ' ILE . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.31 111.178 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.41 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.31 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.03 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.44 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.13 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 62.34 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.688 HD12 HD11 ' A' ' 33' ' ' LEU . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.34 110.908 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.649 HD12 ' HA2' ' A' ' 54' ' ' GLY . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 64.02 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.141 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.03 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 44.55 112.515 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 64.2 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 52.22 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.45 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.31 110.811 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.44 112.311 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 43.42 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 44.41 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.586 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.33 111.206 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 23.14 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.52 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.648 HG11 ' CE1' ' A' ' 29' ' ' PHE . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.55 111.064 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 71.22 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.52 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 64.24 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.54 110.769 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.658 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.41 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.2 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' SER . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.893 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 73.43 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.71 ' CG2' HG11 ' A' ' 42' ' ' VAL . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 70.24 111.191 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 50' ' ' ILE . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 74.44 111.32 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 33.53 112.309 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.751 0.31 . . . . 63.34 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 70.21 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.4 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.13 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.33 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 18' ' ' TYR . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.41 110.843 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.34 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 74.25 111.047 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.232 0.224 0 CA-C-O 121.112 0.38 . . . . 61.2 112.322 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.41 111.017 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.54 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.44 111.16 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 20' ' ' VAL . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 62.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 62.4 111.408 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.52 112.34 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.55 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.32 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.2 111.236 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.33 112.585 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.03 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.12 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.042 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 27' ' ' THR . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.03 111.18 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.12 110.935 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.54 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.23 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.965 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.22 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.1 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.32 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 70.31 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 63.42 111.354 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.66 ' O ' HD11 ' A' ' 76' ' ' ILE . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 61.4 112.068 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.35 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 54.42 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.34 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.42 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.52 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.51 111.12 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA2' ' A' ' 54' ' ' GLY . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 64.22 111.191 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.54 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.13 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.45 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.676 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.42 112.445 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.22 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 72.12 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 HG12 ' A' ' 66' ' ' VAL . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.31 111.05 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.52 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.13 112.297 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.15 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 64.24 111.004 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.13 110.947 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 34.23 110.971 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.32 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 71.32 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 70.43 111.111 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.21 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.12 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 53.43 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.13 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.44 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.22 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.34 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.58 ' NH1' HD11 ' A' ' 50' ' ' ILE . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.89 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 43' ' ' PRO . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 71.35 111.389 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ILE . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 70.32 111.331 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.14 112.144 -179.572 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.87 0.366 . . . . 71.44 110.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 65.55 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 67' ' ' PHE . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.3 111.255 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.13 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.24 110.86 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.41 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 76' ' ' ILE . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.11 111.088 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.027 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.43 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 CA--C 1.527 0.141 0 CA-C-O 120.87 0.279 . . . . 74.13 112.146 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.71 ' HB2' HG22 ' A' ' 9' ' ' THR . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.04 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.22 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 6' ' ' PHE . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.32 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 72.52 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 71.51 111.129 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.45 112.358 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.14 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.14 111.116 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 45.01 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.726 ' CE1' HG11 ' A' ' 66' ' ' VAL . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 61.4 110.813 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.42 111.186 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.086 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 44.05 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 HG13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 61.13 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.21 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 76' ' ' ILE . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 32.22 110.939 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.15 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 74.53 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.783 HG11 HG22 ' A' ' 76' ' ' ILE . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 63.11 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.21 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.54 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.32 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 64.51 111.137 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.655 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.24 110.886 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' HA2' ' A' ' 54' ' ' GLY . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 62.43 111.111 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 55' ' ' ILE . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.14 111.215 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.42 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 53.13 112.384 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.75 HG22 ' OG1' ' A' ' 51' ' ' THR . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.45 111.094 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 65.44 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HD11 ' CG2' ' A' ' 51' ' ' THR . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 70.31 111.268 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.41 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.41 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 52.43 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 72.15 111.154 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.13 111.256 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.12 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.24 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG11 ' CE1' ' A' ' 29' ' ' PHE . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 72.14 111.151 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 4' ' ' VAL . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.41 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 71.11 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.01 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.14 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.12 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.04 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 49' ' ' ILE . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.44 111.01 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.542 HH21 HD11 ' A' ' 50' ' ' ILE . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.783 HG22 HG11 ' A' ' 42' ' ' VAL . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 60.52 111.027 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 65.12 111.128 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.32 112.449 179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 121.094 0.474 . . . . 44.31 110.75 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 64.32 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 33.21 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.3 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.642 ' HE2' HD23 ' A' ' 74' ' ' LEU . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 53.42 110.94 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 64.32 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 45.13 111.179 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.647 HG22 ' HB2' ' A' ' 18' ' ' TYR . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.091 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 41' ' ' LYS . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.846 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 60.31 111.111 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 CA--C 1.53 0.281 0 CA-C-O 120.853 0.272 . . . . 74.21 112.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.53 110.825 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 6' ' ' PHE . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.169 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD23 HG13 ' A' ' 23' ' ' VAL . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.15 110.645 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.34 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG13 HD23 ' A' ' 21' ' ' LEU . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.03 111.25 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 61.32 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 60.11 111.193 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' N ' HG23 ' A' ' 27' ' ' THR . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 64.01 112.188 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.24 110.929 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.2 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.067 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 27' ' ' THR . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.093 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD23 HD13 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 71.41 110.965 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 44.21 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 52.22 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.2 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.31 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' VAL . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.928 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' CG ' HD13 ' A' ' 10' ' ' LEU . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 62.11 110.935 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 71.32 111.204 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 62.1 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 63.12 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.53 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.3 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.969 HG22 HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 65.01 111.058 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' ILE . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 71.51 111.181 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.42 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 45.25 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.2 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.51 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 63.52 111.301 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 64.14 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 65.3 112.36 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 66' ' ' VAL . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.05 111.116 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.702 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 62.15 111.171 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.43 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 70.02 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 62' ' ' THR . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 64.11 111.195 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 64.11 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 63.45 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 54.43 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.12 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 45.52 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 63.04 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.21 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.969 HD11 HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 52.33 110.776 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.05 110.957 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' ILE . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.11 111.016 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 50.52 111.184 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 55.02 112.201 -179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.997 0.427 . . . . 70.13 110.865 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.24 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 73.11 110.709 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 61.43 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.682 ' CG2' HD11 ' A' ' 76' ' ' ILE . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.973 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 51.03 111.256 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.11 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.192 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.234 0.292 0 CA-C-O 120.844 0.268 . . . . 74.32 112.363 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.34 111.051 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 64.05 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.1 111.026 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 64.25 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.33 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 6' ' ' PHE . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 65.03 111.155 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.24 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.41 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.04 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.42 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.33 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 66' ' ' VAL . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.735 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 62.33 111.113 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.413 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 73.12 111.263 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 29' ' ' PHE . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 64.33 111.016 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.3 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.11 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.064 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.35 111.121 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.24 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.13 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 61.51 110.906 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 61.3 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 64.12 111.165 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.14 112.398 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.12 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 44.32 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.42 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 53.2 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.32 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.814 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 72.23 111.17 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 54' ' ' GLY . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 63.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 51.03 111.113 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.12 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 62.51 112.485 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 61.01 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.31 112.716 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 56' ' ' GLY . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 64.4 111.16 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.23 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.3 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.34 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.31 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.15 111.221 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.15 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 61.53 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.04 111.187 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 73.24 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.15 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.32 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 55.44 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.21 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.41 110.859 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.35 110.855 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 49' ' ' ILE . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.12 110.855 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.447 ' NH2' HD11 ' A' ' 50' ' ' ILE . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.22 110.777 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.836 HG21 HG21 ' A' ' 42' ' ' VAL . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.44 110.966 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 73.24 111.339 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.05 112.306 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.742 0.306 . . . . 65.44 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.33 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 61.23 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 55.43 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD13 ' A' ' 74' ' ' LEU . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.23 110.818 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 70.32 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 36' ' ' ALA . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 53.02 110.93 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.52 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 40' ' ' PHE . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 72.43 110.785 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.53 111.141 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 CA-C-O 120.674 0.197 . . . . 72.22 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.2 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.44 110.784 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 65.11 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.3 111.023 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.24 110.879 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.4 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 27' ' ' THR . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.55 112.273 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.02 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.1 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 60.04 111.18 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.824 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 65.1 112.451 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 73.14 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 63.4 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.11 110.852 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' PRO . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 55.51 111.101 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.43 110.924 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 71.51 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.22 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 8' ' ' ILE . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.33 111.277 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.52 111.147 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 72.21 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.2 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.966 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.24 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.759 HG11 HG22 ' A' ' 76' ' ' ILE . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.32 111.251 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.32 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 54.03 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.4 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 61.32 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' C ' HG23 ' A' ' 76' ' ' ILE . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.14 110.941 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.741 HG22 ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.54 110.846 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.426 HD11 HD11 ' A' ' 77' ' ' ILE . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.4 111.152 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' HIS . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.42 111.167 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.23 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.32 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 70.42 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 ' CG1' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.31 111.152 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.34 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.43 112.388 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 52.42 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.13 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.67 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.41 111.268 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.53 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.1 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.44 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 62' ' ' THR . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.23 110.889 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.21 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.35 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HB3' HG22 ' A' ' 51' ' ' THR . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 63.1 110.777 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.4 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.12 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 73.23 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' CD2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.1 111.019 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.66 HH21 HD13 ' A' ' 77' ' ' ILE . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.93 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.759 HG22 HG11 ' A' ' 42' ' ' VAL . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.759 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.66 HD13 HH21 ' A' ' 75' ' ' ARG . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.12 111.169 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 71.24 112.213 -179.872 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 52.12 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 5' ' ' SER . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.4 111.177 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 4' ' ' VAL . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.901 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 74' ' ' LEU . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.54 110.588 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.907 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' ILE . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 63.1 111.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 18' ' ' TYR . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.43 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.889 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.218 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 CA--C 1.522 -0.094 0 CA-C-O 120.735 0.223 . . . . 72.42 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.591 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG23 ' HG3' ' A' ' 7' ' ' LYS . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.22 111.077 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.53 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 62.24 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 43.42 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.54 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.951 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.23 111.2 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 60.34 112.595 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.701 ' CE2' HG11 ' A' ' 66' ' ' VAL . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.15 110.841 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.33 111.166 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 71.25 111.076 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 28' ' ' PRO . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.23 111.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.03 111.236 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 70.12 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.22 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.31 111.006 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.01 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' HD22 ' A' ' 10' ' ' LEU . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 63.53 111.015 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 71.04 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 71.15 111.28 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 64.23 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 64.44 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.42 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 70.13 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 51.43 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.21 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.923 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.43 111.097 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 71.32 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.3 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 42.43 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.52 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.23 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 66' ' ' VAL . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 70.15 110.971 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.52 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.22 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 70.21 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 65.11 111.077 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.01 111.01 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 53.13 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.4 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 62' ' ' THR . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.125 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.21 110.923 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 64.44 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.1 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.1 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 74' ' ' LEU . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 34.34 110.863 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.923 HD23 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.773 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.41 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' HB ' HG11 ' A' ' 42' ' ' VAL . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.201 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 71.52 111.244 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.13 112.26 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.996 0.427 . . . . 72.22 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 72.44 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 65.31 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.02 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 76' ' ' ILE . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 62.51 111.148 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.12 111.077 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.617 HD12 ' OG1' ' A' ' 11' ' ' THR . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.737 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.617 ' OG1' HD12 ' A' ' 10' ' ' LEU . 96.9 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.54 111.067 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.906 0.294 . . . . 73.1 112.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.911 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 70.45 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 54.21 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 65.54 110.727 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 44.4 110.916 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 22' ' ' SER . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.35 111.219 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.66 ' O ' HG22 ' A' ' 27' ' ' THR . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.41 112.334 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 55.54 110.643 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.31 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' PRO . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.1 111.14 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.51 112.391 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.53 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 64.14 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 61.24 111.004 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 28' ' ' PRO . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 71.35 111.063 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.34 111.139 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 73.05 110.86 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 63.21 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.1 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 51.54 111.334 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.53 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 21' ' ' LEU . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 72.44 110.755 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 71.54 110.901 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 72.52 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.33 111.102 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 32.43 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.44 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.3 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 77' ' ' ILE . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.11 111.111 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' HG ' ' A' ' 33' ' ' LEU . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.32 111.085 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.32 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 52.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.34 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 63.01 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.54 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 64.34 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 61.34 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.04 111.085 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.45 110.927 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 54.44 112.399 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.3 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.3 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.3 111.356 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 25' ' ' GLU . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.13 111.218 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.23 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 62.44 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 62' ' ' THR . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 60.31 111.212 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 64.21 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 74.2 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 73.53 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.603 ' HB3' HG21 ' A' ' 51' ' ' THR . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 73.03 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.33 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.33 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 71.32 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.22 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 8' ' ' ILE . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.23 111.176 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 48' ' ' ALA . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 65.24 111.286 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 73.53 112.386 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.496 0.498 . . . . 45.03 112.814 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.4 120.84 7.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.673 2.249 . . . . 45.12 112.275 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mt -137.84 145.56 42.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.992 -0.549 . . . . 63.23 110.57 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.04 104.28 0.19 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.531 -0.842 . . . . 73.11 112.395 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 49.2 m -151.26 173.31 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 71.12 110.979 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptp -178.76 -36.37 0.01 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.259 -0.428 . . . . 72.41 110.833 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -151.03 126.35 10.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.459 . . . . 53.53 110.686 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.3 155.52 45.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.1 -0.5 . . . . 74.41 110.82 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -153.52 156.9 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 73.34 111.192 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 m -102.15 114.72 29.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 71.31 110.872 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -97.36 138.27 35.07 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.998 -0.546 . . . . 60.04 111.014 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 64.03 111.031 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.759 HD12 HD22 ' A' ' 21' ' ' LEU . 2.8 mt -119.76 101.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.227 -0.442 . . . . 73.33 111.211 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.1 p -92.18 124.42 36.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.46 . . . . 71.13 111.149 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -80.08 -34.85 37.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.817 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.03 -35.39 2.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.137 -0.483 . . . . 71.42 111.17 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.73 30.13 6.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 55.23 110.819 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.15 160.48 65.51 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.699 0.761 . . . . 72.43 110.859 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.61 -31.89 20.3 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.793 2.329 . . . . 51.3 112.273 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -70.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 74.2 110.835 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.33 160.67 31.39 Favored Pre-proline 0 N--CA 1.455 -0.19 0 CA-C-O 121.503 0.668 . . . . 75.52 111.161 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.97 -170.93 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.578 2.185 . . . . 73.02 112.111 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.775 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.0 p90 -108.96 166.72 10.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 75.15 110.907 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.24 111.33 23.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.085 -0.507 . . . . 72.32 110.736 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 p -126.11 123.29 63.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 71.03 111.195 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.759 HD22 HD12 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -120.3 175.7 5.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 62.24 110.919 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.7 p -124.19 126.08 45.52 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.136 -0.484 . . . . 60.43 111.001 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.93 156.18 47.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.757 0.789 . . . . 60.45 110.99 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 176.7 6.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.64 2.226 . . . . 73.41 112.329 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -86.22 -30.71 22.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.061 0.457 . . . . 74.33 110.871 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.27 73.92 8.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.081 0.467 . . . . 63.33 110.857 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.05 154.48 20.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.762 0.791 . . . . 64.31 110.966 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 32' ' ' VAL . 52.6 Cg_endo -69.72 98.76 0.7 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.56 2.173 . . . . 74.5 112.297 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.691 ' CE2' HG11 ' A' ' 66' ' ' VAL . 74.1 t80 -50.17 -56.94 8.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.982 0.42 . . . . 72.22 111.082 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.26 -53.6 27.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 55.5 111.064 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.48 -60.1 3.52 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.237 -0.438 . . . . 72.23 111.313 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 28' ' ' PRO . 44.3 t -53.23 -46.81 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.07 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 49' ' ' ILE . 1.1 tp -57.94 -67.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 73.14 111.103 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.58 -32.68 29.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.152 -0.476 . . . . 53.42 111.03 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.67 -70.3 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 74.14 111.004 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -60.66 -47.0 88.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.062 -0.517 . . . . 73.11 111.083 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -53.03 -40.09 63.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 73.52 110.864 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -56.6 -33.18 65.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.343 -0.39 . . . . 75.32 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -3.09 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.161 0.505 . . . . 74.34 110.899 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.65 ' HB3' HD22 ' A' ' 10' ' ' LEU . 22.8 m-85 -106.0 22.88 14.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.106 0.479 . . . . 73.22 111.05 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.57 20.31 11.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.884 -0.598 . . . . 64.43 110.897 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.552 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -131.69 87.58 45.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.316 0.579 . . . . 74.45 110.921 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 76' ' ' ILE . 54.4 Cg_endo -69.8 166.27 28.2 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.573 2.182 . . . . 55.03 112.643 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.24 -13.9 9.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 53.31 111.039 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.08 -50.69 65.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 72.11 111.27 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.39 -23.08 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 74.2 111.142 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.59 165.05 12.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.988 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.0 168.23 10.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.343 -0.389 . . . . 63.23 111.164 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -124.35 134.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.114 0.483 . . . . 74.21 111.061 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -144.83 164.72 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.993 -0.549 . . . . 65.04 111.083 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 70' ' ' HIS . 28.8 p -84.47 -177.11 6.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.265 -0.425 . . . . 73.01 111.125 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -51.3 -45.97 62.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.861 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.61 -28.65 56.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.038 0.447 . . . . 71.54 111.104 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.64 81.24 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.748 -0.739 . . . . 44.3 112.59 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.3 mt -135.09 148.69 28.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.78 0.324 . . . . 72.12 111.073 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.42 155.8 51.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 44.32 112.428 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.599 HD13 ' CD2' ' A' ' 70' ' ' HIS . 7.1 tp -135.2 147.04 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 74.25 111.084 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 3.6 m-20 -93.49 108.21 32.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.699 0.762 . . . . 71.23 110.83 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 53.0 Cg_endo -69.59 -6.63 18.98 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.86 2.373 . . . . 74.34 112.379 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 7.68 23.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 55.02 110.814 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -110.89 173.64 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.949 0.404 . . . . 70.15 110.812 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.1 p -95.22 166.63 11.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 53.22 111.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.55 -35.15 28.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 72.05 111.049 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.06 -51.06 54.32 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.928 -0.654 . . . . 60.22 112.461 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.46 -38.46 84.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.91 0.386 . . . . 75.2 110.916 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG11 ' CE2' ' A' ' 29' ' ' PHE . 58.3 t -77.33 -25.5 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 72.35 111.178 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -81.02 -25.29 37.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.107 -0.497 . . . . 75.13 110.782 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.76 -52.35 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 75.52 110.925 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -56.0 21.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 63.12 110.807 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.599 ' CD2' HD13 ' A' ' 57' ' ' ILE . 30.3 m-70 -82.81 -60.55 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.367 -0.378 . . . . 71.24 110.805 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.79 -71.49 0.41 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.013 -0.613 . . . . 61.31 112.703 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.5 t 179.92 -34.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.875 0.369 . . . . 74.22 110.976 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.25 108.23 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 65.04 110.792 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.65 148.88 39.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 54.13 111.042 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.42 160.88 31.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 63.11 110.962 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 77' ' ' ILE . 4.8 tt -123.7 140.6 46.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 75.21 111.281 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -165.24 159.07 14.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.538 0.685 . . . . 64.13 111.137 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.1 144.63 52.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.547 2.164 . . . . 74.44 112.217 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -100.41 -31.19 11.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.391 . . . . 73.24 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 173.75 12.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.847 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.99 151.75 33.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.1 t -136.16 -42.63 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.154 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 64.11 112.509 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.281 0.378 . . . . 74.14 112.739 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.68 28.52 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.531 2.154 . . . . 64.32 112.419 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -126.83 163.46 23.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.942 0.401 . . . . 70.11 110.85 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 130.92 -164.63 23.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.876 -0.678 . . . . 54.11 112.509 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.7 m -95.27 -60.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.063 0.459 . . . . 71.42 110.997 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttm -173.77 58.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 53.43 110.846 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -172.86 125.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 64.43 111.0 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -144.02 -177.94 5.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 62.14 110.948 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.442 HG21 ' HA2' ' A' ' 64' ' ' GLY . 33.0 m -144.8 171.31 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.487 -0.324 . . . . 64.32 111.146 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 m -83.11 169.98 15.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.222 -0.445 . . . . 74.42 110.663 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' CZ ' HD11 ' A' ' 8' ' ' ILE . 9.5 t80 -157.22 108.7 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.025 -0.534 . . . . 75.12 110.793 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.73 113.69 26.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.951 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.582 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 23.9 mm -114.74 118.07 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.244 -0.435 . . . . 73.4 110.79 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.3 p -128.97 114.42 16.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.12 111.127 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -101.62 0.18 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.576 . . . . 52.11 111.146 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER 179.78 -30.88 0.01 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.13 -0.487 . . . . 62.04 111.109 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t 68.78 9.98 7.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.037 0.446 . . . . 72.34 110.921 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.74 161.9 0.11 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 72.4 110.924 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 -14.29 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.854 2.369 . . . . 65.51 112.289 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -158.81 -41.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.96 0.41 . . . . 72.01 110.98 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -56.86 162.63 3.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.582 0.706 . . . . 60.53 110.937 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.63 167.57 23.9 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.678 2.252 . . . . 72.03 112.548 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.735 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.23 -174.36 4.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.003 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.15 122.48 44.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.163 -0.472 . . . . 71.34 111.02 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.3 p -137.94 124.24 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.43 111.034 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.7 mt -135.19 175.68 9.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.785 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.4 p -105.72 148.03 27.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 72.23 110.842 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 24' ' ' PRO . 67.2 t -149.98 133.6 8.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.853 0.835 . . . . 74.42 110.933 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 23' ' ' VAL . 55.2 Cg_endo -69.68 171.35 14.54 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 73.22 112.4 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 -27.83 23.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 71.03 111.037 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -89.89 69.29 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 64.34 110.916 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -159.99 148.83 13.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.85 0.833 . . . . 74.5 110.956 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.655 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 55.2 Cg_endo -69.72 124.1 10.77 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.455 2.104 . . . . 74.24 112.548 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.486 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.1 t80 -63.41 -58.8 5.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 73.34 110.631 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.3 t -47.72 -46.76 29.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.193 -0.458 . . . . 54.11 111.145 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -60.03 -61.5 2.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 61.23 110.844 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 28' ' ' PRO . 90.4 t -52.93 -34.16 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 65.34 111.108 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -62.79 -69.64 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.407 . . . . 63.12 110.984 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -29.41 64.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.189 -0.459 . . . . 54.33 110.926 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -62.09 -65.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 71.41 110.885 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -66.37 -43.51 85.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.14 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -56.32 -38.72 71.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.078 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -52.95 -34.89 57.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.406 . . . . 73.35 110.988 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -90.53 -15.51 30.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 60.52 110.753 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' HB3' HD22 ' A' ' 10' ' ' LEU . 21.6 m-85 -89.77 11.04 21.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.11 110.736 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 tttt 63.84 27.18 14.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 53.22 110.878 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.6 m -130.64 119.62 18.34 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.545 0.688 . . . . 63.54 111.367 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.55 -177.39 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.69 2.26 . . . . 72.43 112.75 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.32 -24.67 7.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.545 -0.298 . . . . 54.21 111.031 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.08 -50.41 4.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.342 -0.39 . . . . 74.13 111.025 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -41.78 90.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 74.44 111.016 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.6 t -100.57 166.33 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.425 . . . . 62.0 110.937 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.34 162.13 22.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.278 -0.419 . . . . 63.53 111.164 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.735 HD13 HD11 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -121.05 99.36 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.246 0.546 . . . . 41.34 111.01 -179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA2' ' A' ' 54' ' ' GLY . 26.9 pt -109.48 139.29 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.52 . . . . 61.52 111.162 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -176.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 72.41 111.162 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -51.72 -49.18 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.371 -0.377 . . . . 70.1 110.808 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 -30.1 71.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.44 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 98.68 57.15 0.99 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.72 -0.752 . . . . 63.1 112.523 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.8 tt -122.45 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.36 . . . . 75.35 111.113 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.35 172.2 0.36 Allowed Glycine 0 C--O 1.23 -0.12 0 C-N-CA 120.74 -0.743 . . . . 71.23 112.47 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 HG12 ' A' ' 66' ' ' VAL . 2.4 tt -134.5 158.85 42.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.837 0.351 . . . . 75.33 111.175 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.6 96.56 7.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.548 0.69 . . . . 71.13 110.858 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.64 -8.83 24.62 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.752 2.301 . . . . 64.24 112.222 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.62 68.65 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 52.53 111.221 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -173.93 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.941 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -85.39 150.86 24.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 62.31 110.988 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.743 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -62.54 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 63.5 111.075 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 4' ' ' VAL . . . -51.74 -41.83 51.42 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 120.729 -0.748 . . . . 73.21 112.371 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.38 -40.88 96.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.768 0.318 . . . . 63.33 110.922 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 62' ' ' THR . 48.3 t -73.97 -24.7 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.21 -0.45 . . . . 63.43 111.349 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 18.8 m-85 -85.39 -25.23 27.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 54.44 111.049 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -91.16 -24.42 19.96 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.018 -0.537 . . . . 74.12 110.825 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -70.37 -55.79 8.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 74.21 111.028 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -97.07 -43.72 7.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 61.52 110.745 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.76 141.94 4.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.855 -0.688 . . . . 74.41 112.455 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -57.15 -26.51 60.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 72.25 110.919 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.8 107.39 15.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 54.45 110.869 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 8' ' ' ILE . 2.4 pp -140.64 153.42 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 71.32 110.955 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.08 166.95 13.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 73.04 110.878 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.5 tt -133.3 142.52 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.453 -0.34 . . . . 53.43 111.37 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -169.9 158.36 6.53 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.643 0.735 . . . . 75.12 110.949 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.51 133.14 25.3 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.805 2.337 . . . . 52.42 112.515 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.67 174.0 8.28 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.054 -0.521 . . . . 75.12 110.899 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 t0 57.93 -176.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 75.31 110.87 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -44.56 7.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 73.44 110.961 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 t -133.99 -44.72 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.983 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.943 -0.646 . . . . 53.1 112.474 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-O 121.318 0.399 . . . . 53.22 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.97 -171.3 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.581 2.188 . . . . 62.23 112.186 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.73 167.7 6.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 75.41 111.017 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -131.21 143.61 15.07 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.925 -0.655 . . . . 52.12 112.583 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.88 141.4 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.879 0.371 . . . . 54.34 110.787 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt -62.37 -62.7 1.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.5 110.767 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.66 136.33 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 70.52 110.615 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -143.98 157.57 44.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.987 -0.551 . . . . 65.44 110.855 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 m -153.26 166.34 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 64.2 111.155 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.06 162.71 22.47 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.064 -0.516 . . . . 75.32 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -149.57 109.42 4.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.897 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -89.48 106.24 18.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.994 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 6' ' ' PHE . 19.9 mm -107.33 98.91 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.235 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 18' ' ' TYR . 11.7 p -104.42 131.19 52.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.195 -0.457 . . . . 53.4 111.395 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.19 -15.99 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.276 -0.42 . . . . 64.24 110.792 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.89 -40.66 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 54.34 111.246 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.1 31.03 6.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 64.33 110.815 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.13 161.18 0.76 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.568 0.699 . . . . 74.44 110.832 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -33.61 15.95 Favored 'Trans proline' 0 N--CA 1.471 0.193 0 C-N-CA 122.696 2.264 . . . . 70.04 112.186 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -55.91 -70.15 0.12 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.174 -0.467 . . . . 73.13 110.811 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.49 160.4 26.37 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.6 0.714 . . . . 71.23 110.886 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.86 -178.16 2.25 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.636 2.224 . . . . 73.4 112.303 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.784 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.5 p90 -88.31 -179.35 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.235 0.54 . . . . 73.41 110.805 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.63 27.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.066 -0.515 . . . . 74.12 111.076 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.5 p -114.99 126.17 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.083 -0.508 . . . . 54.04 111.264 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.4 mt -135.37 160.6 37.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.498 . . . . 73.2 111.047 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -96.21 146.24 24.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 73.2 111.12 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' HD2' ' A' ' 24' ' ' PRO . 57.3 t -148.84 133.38 8.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.934 0.873 . . . . 44.0 110.883 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 23' ' ' VAL . 53.8 Cg_endo -69.9 170.36 16.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.722 2.281 . . . . 74.44 112.342 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -85.22 -25.38 27.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 65.5 110.944 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -100.28 74.56 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.78 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.08 153.49 20.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.7 0.762 . . . . 70.34 111.168 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.68 107.94 1.95 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.552 2.168 . . . . 73.11 112.365 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.648 ' CE1' HG11 ' A' ' 66' ' ' VAL . 66.0 t80 -58.74 -56.94 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.802 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.51 -45.63 56.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.227 -0.442 . . . . 74.41 111.108 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.77 -59.47 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.913 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.87 -34.94 45.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.244 -0.435 . . . . 44.42 111.107 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -60.57 -67.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.13 -0.486 . . . . 43.55 110.97 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.1 -41.3 87.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.201 -0.454 . . . . 42.3 110.898 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -51.3 -62.3 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.11 110.77 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.24 82.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.192 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -50.33 -39.09 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.992 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -55.65 -38.09 69.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.327 -0.397 . . . . 73.1 110.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -90.17 -2.85 58.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 75.04 110.99 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' ALA . 5.3 m-85 -106.68 30.95 5.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.932 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.45 18.29 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.47 . . . . 60.23 110.865 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.71 HG11 ' CG2' ' A' ' 76' ' ' ILE . 85.5 t -116.34 127.82 26.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.558 0.694 . . . . 72.31 111.178 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.586 2.19 . . . . 73.41 112.416 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.57 -49.95 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 74.31 111.118 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.68 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.977 0.418 . . . . 65.03 110.975 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.56 28.12 3.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.306 -0.407 . . . . 61.44 111.199 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.03 168.14 15.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 70.13 110.904 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 115.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 62.34 111.158 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.688 HD12 HD11 ' A' ' 33' ' ' LEU . 9.4 tt -114.8 144.59 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.492 0.663 . . . . 72.34 110.908 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.649 HD12 ' HA2' ' A' ' 54' ' ' GLY . 7.6 pt -145.68 167.23 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 64.02 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -78.62 179.67 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.141 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -54.38 -36.35 63.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.702 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.82 24.84 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.409 -0.36 . . . . 74.03 111.119 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 55.33 23.4 33.85 Favored Glycine 0 CA--C 1.515 0.09 0 C-N-CA 120.639 -0.791 . . . . 44.55 112.515 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 46.4 mm -70.78 142.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.739 0.304 . . . . 64.2 111.36 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -53.58 162.64 2.99 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.923 -0.656 . . . . 52.22 112.593 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -141.55 145.49 24.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.925 0.393 . . . . 74.45 110.962 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 m-80 -100.59 100.96 13.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.607 0.718 . . . . 73.31 110.811 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 54.5 Cg_endo -69.86 -8.44 23.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.648 2.232 . . . . 73.44 112.311 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.69 75.18 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 43.42 111.265 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -174.7 -169.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.54 110.963 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 153.39 18.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 44.41 111.26 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.586 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.59 -56.61 12.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 72.33 111.206 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.05 -46.38 41.95 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.936 -0.649 . . . . 23.14 112.628 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -59.15 -49.29 78.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 52.52 110.885 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.648 HG11 ' CE1' ' A' ' 29' ' ' PHE . 48.9 t -67.92 -21.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.801 0.334 . . . . 73.55 111.064 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -40.75 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 71.22 110.779 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.0 -13.27 33.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 70.52 111.034 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -56.24 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 64.24 110.783 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HB3' HG21 ' A' ' 51' ' ' THR . 52.1 m-70 -112.07 -42.26 3.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 64.54 110.769 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.41 151.57 5.82 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.379 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.658 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.1 p -50.94 -27.87 8.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 71.41 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -64.61 90.29 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.04 -0.527 . . . . 71.2 110.77 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' SER . 2.2 mp -113.78 158.95 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.893 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -155.69 126.14 6.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 73.43 110.601 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.71 ' CG2' HG11 ' A' ' 42' ' ' VAL . 8.6 mt -105.02 144.07 15.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.528 . . . . 70.24 111.191 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 HD11 HD11 ' A' ' 50' ' ' ILE . 5.0 pt -156.6 156.43 29.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 74.44 111.32 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 131.32 20.72 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.569 2.179 . . . . 33.53 112.309 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.13 143.76 45.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 54.03 110.867 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 62.0 179.16 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 60.02 110.905 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -130.99 175.18 9.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.758 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.87 169.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 74.32 111.146 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.614 -0.803 . . . . 75.34 112.416 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.491 0.495 . . . . 74.12 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.75 157.28 60.96 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.581 2.187 . . . . 71.23 112.414 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 21.0 mt -119.12 68.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 71.51 110.806 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.84 -147.51 15.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 73.44 112.576 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -143.47 82.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.01 0.434 . . . . 32.51 110.824 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -60.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.998 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -179.36 149.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.054 -0.521 . . . . 63.34 111.044 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -143.91 156.59 44.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.349 -0.387 . . . . 70.21 111.027 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.3 m -150.67 -175.1 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.899 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 m -94.13 175.39 6.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 73.4 110.804 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.5 109.41 2.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.081 -0.509 . . . . 75.13 110.962 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.04 117.86 25.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.983 -0.553 . . . . 71.33 110.737 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.92 92.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.998 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.756 HG22 ' HB2' ' A' ' 18' ' ' TYR . 23.4 p -86.5 131.91 34.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.224 -0.444 . . . . 73.41 110.843 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.16 1.37 54.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.34 110.746 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 13' ' ' ASP . 14.0 t -175.82 -34.81 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.051 0.453 . . . . 74.25 111.047 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p 49.49 50.19 18.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.278 -0.419 . . . . 72.12 110.779 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' OD2' HD13 ' A' ' 16' ' ' LEU . 17.6 p-10 -51.56 153.62 3.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.572 0.701 . . . . 62.34 110.981 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.73 149.25 66.81 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.729 2.286 . . . . 74.25 112.346 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.602 ' O ' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER 53.53 44.79 29.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.609 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -163.31 160.24 18.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.326 0.584 . . . . 62.34 111.005 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' HD23 ' A' ' 16' ' ' LEU . 54.9 Cg_endo -69.54 -170.8 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.632 2.222 . . . . 61.2 112.322 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.756 ' HB2' HG22 ' A' ' 9' ' ' THR . 5.4 p90 -141.94 -176.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.41 111.017 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.72 123.12 46.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.54 110.908 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' HD23 ' A' ' 21' ' ' LEU . 6.7 p -137.96 124.26 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.44 111.16 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 20' ' ' VAL . 42.7 mt -124.02 148.71 46.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 62.0 111.026 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.5 p -87.21 143.02 27.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 74.32 111.021 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.0 t -149.14 133.22 8.77 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.443 0.64 . . . . 62.4 111.408 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.5 Cg_endo -69.59 179.93 3.26 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.675 2.25 . . . . 62.52 112.34 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.41 -25.89 26.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 64.55 110.883 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 p -104.36 72.05 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 74.32 110.978 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -154.13 148.44 19.25 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 121.289 0.566 . . . . 73.2 111.236 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.7 Cg_endo -69.79 108.45 2.09 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.546 2.164 . . . . 75.33 112.585 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -54.42 -55.46 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.03 110.547 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -50.83 -55.25 17.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 74.12 111.17 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.12 -61.27 2.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.042 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 27' ' ' THR . 88.4 t -53.63 -36.22 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.03 111.18 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -58.69 -68.77 0.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 74.12 110.935 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 pttp -59.69 -29.51 68.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.176 -0.466 . . . . 73.24 110.827 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.27 -61.49 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 72.54 111.013 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.72 -44.73 55.54 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.168 -0.469 . . . . 63.23 111.189 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -52.67 -38.48 60.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.965 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -52.96 -34.23 54.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 71.22 110.774 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -90.23 -17.29 27.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.1 110.88 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -88.78 9.57 24.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.24 0.543 . . . . 75.32 111.212 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt 64.03 28.47 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.914 -0.584 . . . . 70.31 110.901 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' HB1' ' A' ' 37' ' ' ALA . 1.5 m -129.43 119.44 19.43 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.618 0.723 . . . . 63.42 111.354 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.66 ' O ' HD11 ' A' ' 76' ' ' ILE . 53.0 Cg_endo -69.91 154.46 67.13 Favored 'Trans proline' 0 N--CA 1.472 0.207 0 C-N-CA 122.678 2.252 . . . . 61.4 112.068 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.85 -20.33 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 74.35 111.274 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.94 -50.44 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 54.42 111.149 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -60.85 2.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 75.34 111.248 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.8 p -85.03 171.98 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 73.42 110.865 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.07 170.81 9.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.106 -0.497 . . . . 62.52 111.038 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.808 HD13 HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -121.58 145.29 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 74.51 111.12 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA2' ' A' ' 54' ' ' GLY . 41.8 pt -142.7 151.14 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 64.22 111.191 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.9 p -69.36 176.16 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.54 111.027 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -53.64 -28.3 32.14 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.13 110.859 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -81.11 -31.14 34.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 75.45 110.848 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.676 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 99.55 68.07 0.87 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.691 . . . . 74.42 112.445 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.8 mt -138.61 147.59 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.534 0.207 . . . . 75.22 111.237 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.06 166.29 1.04 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 72.12 112.355 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.501 HD11 HG12 ' A' ' 66' ' ' VAL . 2.1 tt -126.88 157.93 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.83 0.348 . . . . 73.31 111.05 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.77 92.66 4.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.332 0.587 . . . . 73.52 110.946 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.0 Cg_endo -69.78 -12.0 31.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.585 2.19 . . . . 73.13 112.297 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.56 67.89 4.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 72.15 111.331 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.62 -177.51 0.82 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.154 -0.475 . . . . 64.24 111.004 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -84.05 153.86 23.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 73.13 110.947 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -51.68 -54.03 32.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.928 0.394 . . . . 34.23 110.971 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.01 -43.73 55.87 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.822 -0.704 . . . . 74.32 112.351 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.85 -47.99 75.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.843 0.354 . . . . 71.32 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 62' ' ' THR . 20.0 t -66.72 -20.44 27.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 70.43 111.111 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -82.47 -41.34 19.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 63.21 110.902 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.52 -39.66 31.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 74.12 111.087 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -52.02 -29.7 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.019 -0.537 . . . . 53.43 110.909 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -111.38 -65.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 75.43 110.795 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.01 -87.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.728 . . . . 62.13 112.303 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 29.1 t -169.29 -38.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.564 0.221 . . . . 71.44 110.759 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.14 128.65 35.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 72.22 111.051 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.18 143.23 29.14 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.104 -0.498 . . . . 74.34 110.822 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.58 ' NH1' HD11 ' A' ' 50' ' ' ILE . 6.5 ptm180 -122.87 146.67 47.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 62.25 110.89 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 43' ' ' PRO . 1.8 tt -108.77 140.48 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.256 -0.429 . . . . 71.35 111.389 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 76' ' ' ILE . 1.9 pt -161.51 158.55 22.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 70.32 111.331 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.06 146.43 58.33 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.539 2.159 . . . . 72.14 112.144 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -91.86 -35.12 14.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 73.15 110.872 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.22 90.49 0.29 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.122 -0.49 . . . . 74.34 111.002 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.28 -62.09 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.445 -0.343 . . . . 73.23 111.112 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -57.07 174.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 72.01 111.234 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 C-N-CA 120.583 -0.818 . . . . 54.45 112.537 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 121.359 0.422 . . . . 75.31 112.636 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.09 -174.18 0.92 Allowed 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.712 2.274 . . . . 74.21 112.282 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.64 79.9 8.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.926 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -62.53 155.57 40.45 Favored Glycine 0 C--O 1.229 -0.187 0 C-N-CA 120.653 -0.784 . . . . 73.12 112.534 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.2 m -163.08 63.62 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 70.44 110.936 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt -117.41 -57.14 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.104 -0.498 . . . . 64.22 110.861 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -163.65 69.28 0.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.514 . . . . 71.44 110.436 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -61.04 159.08 12.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.335 -0.393 . . . . 65.55 111.027 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 67' ' ' PHE . 28.7 m -151.16 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.486 -0.325 . . . . 75.3 111.255 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 99.5 p -85.17 165.95 16.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.362 -0.381 . . . . 74.13 110.78 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.611 ' O ' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -156.94 109.5 2.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 75.24 110.86 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.03 121.04 30.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 73.41 110.789 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.654 HD11 HD12 ' A' ' 76' ' ' ILE . 7.8 tt -122.92 110.26 26.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.059 0.457 . . . . 65.11 111.088 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.9 p -109.81 141.27 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.027 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 -6.37 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 73.43 110.889 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.12 -37.45 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 62.25 111.213 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t 51.14 52.4 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.867 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.82 160.55 0.78 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.515 0.674 . . . . 74.32 110.854 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -44.07 2.26 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.561 2.174 . . . . 62.43 112.329 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -75.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.982 0.42 . . . . 74.02 110.903 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.64 160.6 36.14 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.557 0.694 . . . . 70.21 110.928 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.03 -170.78 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.699 2.266 . . . . 74.13 112.146 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.71 ' HB2' HG22 ' A' ' 9' ' ' THR . 11.7 p90 -87.97 178.94 6.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 70.0 110.979 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.8 125.93 49.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.022 -0.535 . . . . 74.04 110.725 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.06 125.18 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.22 111.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 6' ' ' PHE . 1.9 pt? -129.69 175.66 8.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.231 -0.44 . . . . 72.32 110.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.1 p -102.1 146.93 27.23 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.046 -0.524 . . . . 72.52 110.963 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 24' ' ' PRO . 58.4 t -147.68 133.24 9.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.525 0.678 . . . . 71.51 111.129 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 23' ' ' VAL . 54.3 Cg_endo -69.64 169.82 17.87 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.874 2.383 . . . . 74.45 112.358 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.07 -39.4 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.649 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.3 t -87.73 73.45 9.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 73.14 110.95 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.51 153.84 20.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.583 0.706 . . . . 64.14 111.116 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 113.0 3.22 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.461 2.108 . . . . 45.01 112.532 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.726 ' CE1' HG11 ' A' ' 66' ' ' VAL . 40.4 t80 -61.32 -60.75 3.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.469 . . . . 61.4 110.813 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.8 t -48.28 -45.99 35.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 63.42 111.186 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -58.42 -64.54 0.89 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.18 -0.464 . . . . 71.15 111.086 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.55 -33.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 44.05 111.077 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 HG13 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -61.9 -67.58 0.4 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 75.25 110.933 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.82 -42.02 83.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 61.13 110.876 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -51.83 -59.47 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.796 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 -43.49 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.21 111.194 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 76' ' ' ILE . . . -51.1 -34.01 28.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 32.22 110.939 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.79 -34.11 65.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.275 -0.42 . . . . 63.15 110.726 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.37 -10.41 44.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.788 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.63 27.53 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.843 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.82 19.02 11.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 74.53 110.935 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.783 HG11 HG22 ' A' ' 76' ' ' ILE . 62.5 t -116.42 128.01 26.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.541 0.686 . . . . 73.25 111.416 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.46 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.67 2.246 . . . . 63.11 112.101 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -112.06 -59.76 1.95 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.922 -0.581 . . . . 73.21 111.081 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.37 73.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.14 111.13 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 p -97.3 31.76 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 64.54 111.232 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.06 170.21 13.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.32 110.896 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 79' ' ' ARG . . . -171.75 107.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.16 -0.473 . . . . 64.51 111.137 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.655 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -112.18 138.45 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.47 0.652 . . . . 75.24 110.886 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' HA2' ' A' ' 54' ' ' GLY . 9.0 pt -138.34 165.42 25.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 115.997 -0.547 . . . . 62.43 111.111 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 55' ' ' ILE . 38.5 p -69.99 -172.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 63.14 111.215 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.35 -49.19 78.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.33 -0.395 . . . . 72.42 110.857 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.56 -25.7 63.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.036 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 100.29 51.93 1.19 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.646 -0.788 . . . . 53.13 112.384 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.75 HG22 ' OG1' ' A' ' 51' ' ' THR . 20.9 tt -113.9 151.11 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 75.45 111.094 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.77 156.52 39.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.802 -0.713 . . . . 65.44 112.64 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HD11 ' CG2' ' A' ' 51' ' ' THR . 77.1 mt -140.61 117.64 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.893 0.378 . . . . 70.31 111.268 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -48.38 107.18 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.763 0.792 . . . . 74.41 110.768 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.91 -8.72 24.31 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.69 2.26 . . . . 73.41 112.231 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.94 62.26 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.393 . . . . 52.43 111.219 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.95 -169.58 3.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 3.9 p -106.68 160.27 15.58 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.123 -0.49 . . . . 72.15 111.154 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 27' ' ' THR . . . -50.55 -57.47 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.13 111.256 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -52.26 -47.39 55.88 Favored Glycine 0 C--O 1.227 -0.324 0 C-N-CA 120.335 -0.936 . . . . 71.12 112.427 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -55.97 -43.03 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 72.24 110.777 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.726 HG11 ' CE1' ' A' ' 29' ' ' PHE . 21.6 t -76.66 -20.01 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.061 -0.518 . . . . 72.14 111.151 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 4' ' ' VAL . 37.1 t80 -82.14 -25.97 33.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.33 -0.396 . . . . 74.41 110.862 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tt -90.47 -39.0 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.131 0.491 . . . . 71.11 111.017 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.64 -48.41 63.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.931 -0.577 . . . . 73.0 110.864 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -113.38 -59.13 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 70.01 110.894 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.95 -116.67 0.73 Allowed Glycine 0 C--O 1.227 -0.306 0 C-N-CA 120.588 -0.815 . . . . 62.14 112.365 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.55 25.48 2.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.807 0.337 . . . . 73.12 110.703 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -115.05 96.08 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 72.04 110.953 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.655 HD23 HD11 ' A' ' 49' ' ' ILE . 5.3 mp -120.33 167.58 12.16 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.181 -0.463 . . . . 75.44 111.01 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 HH21 HD11 ' A' ' 50' ' ' ILE . 1.8 ptm180 -158.67 126.93 5.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.783 HG22 HG11 ' A' ' 42' ' ' VAL . 14.8 mt -105.46 140.08 24.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 60.52 111.027 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.3 pt -157.59 156.77 29.29 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.505 0.669 . . . . 65.12 111.128 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.52 118.32 5.61 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.731 2.287 . . . . 65.32 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 9.6 tmm_? -63.44 -37.42 87.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.843 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.09 33.32 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 74.54 110.762 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.22 -174.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.843 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.43 144.61 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 64.23 111.115 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.193 0 C-N-CA 120.765 -0.731 . . . . 72.51 112.474 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 CA-C-O 121.332 0.407 . . . . 54.04 112.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.86 -46.53 1.15 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.597 2.198 . . . . 71.24 112.31 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.46 175.01 8.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 71.12 110.879 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 65.22 57.74 11.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 73.12 112.746 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.5 132.4 31.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.026 0.441 . . . . 65.11 110.739 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm -95.74 88.76 5.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.424 . . . . 73.31 110.776 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 65.03 152.01 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.094 0.474 . . . . 44.31 110.75 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -144.56 158.61 43.69 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.951 -0.568 . . . . 64.32 110.79 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -151.71 165.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.595 -0.275 . . . . 33.21 111.352 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.4 149.71 24.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.289 -0.414 . . . . 72.3 110.889 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.642 ' HE2' HD23 ' A' ' 74' ' ' LEU . 7.9 t80 -134.9 160.22 38.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 53.42 110.94 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -119.44 119.9 35.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 64.32 111.04 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.9 tt -124.89 110.61 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 45.13 111.179 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.647 HG22 ' HB2' ' A' ' 18' ' ' TYR . 12.8 p -108.02 119.24 38.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.091 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 41' ' ' LYS . 1.1 pp -83.76 -24.7 31.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.846 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.44 -40.11 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 60.31 111.111 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.16 29.39 6.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.853 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.75 160.6 43.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.75 0.786 . . . . 74.24 110.811 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -25.59 28.46 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.66 2.24 . . . . 53.43 112.413 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -61.44 -67.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.844 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -101.43 160.29 26.99 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 121.607 0.718 . . . . 75.33 110.832 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HD2' HD23 ' A' ' 16' ' ' LEU . 53.0 Cg_endo -69.63 -179.86 3.14 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.698 2.265 . . . . 74.21 112.228 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.647 ' HB2' HG22 ' A' ' 9' ' ' THR . 20.3 p90 -88.28 165.18 15.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 73.53 110.825 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 mmtm -102.99 129.11 49.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.113 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 6' ' ' PHE . 9.5 p -119.64 129.49 75.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.169 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD23 HG13 ' A' ' 23' ' ' VAL . 1.1 tt -134.1 137.3 44.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.196 -0.456 . . . . 63.15 110.645 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 76.5 p -97.2 143.27 28.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.116 -0.493 . . . . 74.34 111.019 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG13 HD23 ' A' ' 21' ' ' LEU . 1.6 m -148.83 157.34 40.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.591 0.71 . . . . 70.03 111.25 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 168.06 22.59 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.79 2.327 . . . . 61.43 112.362 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.75 -34.36 21.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 61.32 111.008 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.73 74.98 4.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.875 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.559 HG22 ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -159.64 156.3 24.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.653 0.739 . . . . 60.11 111.193 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' N ' HG23 ' A' ' 27' ' ' THR . 52.3 Cg_endo -69.69 112.69 3.14 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.712 2.275 . . . . 64.01 112.188 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.731 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 3.1 t80 -61.7 -58.02 9.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.108 0.48 . . . . 72.24 110.929 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 t -50.84 -44.74 59.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.134 -0.484 . . . . 74.2 111.14 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -61.75 -62.35 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.067 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 27' ' ' THR . 45.3 t -49.37 -47.24 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.093 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD23 HD13 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -58.45 -69.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 71.41 110.965 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -48.47 -32.55 7.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.176 -0.465 . . . . 44.21 110.892 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -60.3 -66.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 75.41 110.941 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.33 -48.87 68.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.114 -0.494 . . . . 52.22 111.136 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 42' ' ' VAL . . . -50.29 -37.64 37.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.09 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -56.04 -35.35 66.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 72.2 110.89 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.39 -14.16 33.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.482 . . . . 73.31 110.75 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 42' ' ' VAL . 6.2 m-85 -94.71 35.45 1.24 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.928 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' CG ' HD13 ' A' ' 10' ' ' LEU . 18.3 ptmt 41.0 38.57 0.7 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.139 -0.482 . . . . 62.11 110.935 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 13.7 m -149.68 81.72 7.01 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 71.32 111.204 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.89 170.32 17.02 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.7 2.267 . . . . 72.0 112.239 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.26 -19.28 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 62.1 111.096 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.74 -50.68 65.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 63.12 110.895 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -24.12 15.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.126 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.35 168.07 9.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.226 0.536 . . . . 74.53 110.577 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.41 160.53 19.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 62.3 111.138 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.969 HG22 HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -115.94 102.13 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 65.01 111.058 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' ILE . 16.2 pt -114.03 137.73 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.902 -0.59 . . . . 71.51 111.181 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.9 p -62.21 175.93 0.66 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.037 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -52.78 -29.85 29.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 65.42 110.849 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.57 -31.24 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.815 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.57 1.27 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.777 -0.725 . . . . 45.25 112.391 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.88 147.54 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 73.2 111.155 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -50.23 166.48 0.47 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.728 -0.749 . . . . 73.51 112.498 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -124.23 156.82 31.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.736 0.303 . . . . 63.52 111.301 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.45 94.29 5.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.7 . . . . 64.14 110.807 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.4 Cg_endo -69.72 -8.71 24.3 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.749 2.299 . . . . 65.3 112.36 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.63 74.63 1.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.23 110.935 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -177.01 -178.16 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.003 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 66' ' ' VAL . 18.2 p -86.39 150.97 23.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.41 -0.359 . . . . 72.05 111.116 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.702 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.28 -61.69 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 62.15 111.171 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.76 -44.44 39.23 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.469 -0.872 . . . . 73.43 112.405 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -63.97 -45.73 87.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.741 0.305 . . . . 70.02 110.856 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 62' ' ' THR . 91.0 t -59.96 -46.43 94.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 64.11 111.195 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 5.0 m-85 -63.48 -41.11 98.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.925 0.393 . . . . 64.11 110.86 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -48.16 68.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 63.45 110.934 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.29 -16.18 59.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.051 -0.522 . . . . 54.43 110.924 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -123.04 22.98 9.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 74.12 110.971 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.64 -82.92 0.38 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.862 -0.685 . . . . 45.52 112.148 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 t 179.92 -33.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 63.04 110.812 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.65 115.92 17.79 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.091 -0.504 . . . . 65.21 110.852 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.969 HD11 HG22 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -138.52 126.81 22.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 52.33 110.776 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -109.04 159.9 16.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 65.05 110.957 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' ILE . 2.4 mt -128.04 137.83 56.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 75.11 111.016 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD11 HD11 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -167.05 159.87 10.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.474 0.654 . . . . 50.52 111.184 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 148.01 63.83 Favored 'Trans proline' 0 C--O 1.222 -0.29 0 C-N-CA 122.675 2.25 . . . . 55.02 112.201 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.32 171.58 11.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.985 -0.552 . . . . 64.41 110.839 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 56.5 -172.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.03 110.943 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -116.7 90.35 3.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.329 -0.396 . . . . 73.54 110.886 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -62.82 167.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.01 -0.541 . . . . 64.54 110.939 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 C-N-CA 120.462 -0.875 . . . . 64.54 112.499 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.632 0.573 . . . . 74.11 112.76 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.7 145.73 58.36 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.744 2.296 . . . . 74.03 112.174 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.332 -0.394 . . . . 72.34 111.165 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 153.56 87.09 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.83 -0.7 . . . . 45.51 112.482 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.52 175.87 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.786 0.327 . . . . 72.13 110.91 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mtt -110.08 -54.73 2.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.53 110.86 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -90.61 112.69 24.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.024 -0.535 . . . . 70.13 110.865 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -144.19 157.88 44.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.792 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.98 178.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.24 111.035 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.6 p -86.16 170.86 11.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.947 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' HG22 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -156.82 109.53 2.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 73.11 110.709 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 113.59 25.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 61.43 110.823 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.682 ' CG2' HD11 ' A' ' 76' ' ' ILE . 2.3 mp -123.32 92.73 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.973 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.76 HG22 ' HB2' ' A' ' 18' ' ' TYR . 19.6 p -85.54 130.41 34.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.171 -0.468 . . . . 51.03 111.256 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.24 -33.33 17.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 73.11 110.716 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.77 -35.18 2.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.192 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.83 29.27 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 75.51 110.797 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.77 160.55 43.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.241 0.544 . . . . 75.15 110.955 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -31.45 20.55 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.632 2.222 . . . . 52.34 112.462 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmt85 -52.11 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 60.43 110.868 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.66 160.63 25.49 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.665 0.745 . . . . 72.4 110.865 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.59 10.74 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.618 2.212 . . . . 74.32 112.363 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.76 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.1 p90 -90.11 163.36 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 75.34 111.051 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -103.23 121.18 42.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.073 -0.512 . . . . 64.05 110.758 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 7.5 p -129.47 124.96 60.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 71.1 111.026 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 20' ' ' VAL . 7.3 mt -132.66 129.29 38.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.244 -0.434 . . . . 64.25 110.866 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.99 146.46 35.39 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.09 -0.505 . . . . 75.33 111.121 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' ' 6' ' ' PHE . 3.1 m -154.33 156.28 31.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.691 -0.686 . . . . 65.03 111.155 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.59 168.21 21.98 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.807 2.338 . . . . 72.24 112.322 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.7 -26.65 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 74.41 110.748 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.1 t -92.64 76.49 4.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.949 0.405 . . . . 64.04 110.795 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.19 154.97 23.0 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 121.54 0.686 . . . . 72.42 111.114 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 111.07 2.71 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.724 2.283 . . . . 62.33 112.333 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 66' ' ' VAL . 63.4 t80 -60.2 -59.21 5.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.735 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 31' ' ' ALA . 2.6 t -49.57 -46.24 48.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.182 -0.463 . . . . 62.33 111.113 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.413 ' N ' HG23 ' A' ' 30' ' ' THR . . . -57.28 -62.38 1.81 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.249 -0.432 . . . . 73.12 111.263 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.4 t -54.19 -33.93 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.164 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 29' ' ' PHE . 1.3 tp -60.53 -69.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 64.33 111.016 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -58.11 -41.05 82.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.3 110.748 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -51.03 -55.39 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.11 110.765 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB1' ' CE2' ' A' ' 40' ' ' PHE . . . -73.77 -36.77 65.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.064 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . -49.22 -44.54 43.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.346 -0.388 . . . . 74.35 111.121 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -55.59 -37.25 67.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.344 -0.389 . . . . 75.24 111.096 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -85.59 -9.03 57.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.516 . . . . 73.13 110.992 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CE2' ' HB1' ' A' ' 36' ' ' ALA . 14.5 m-85 -93.17 20.52 6.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 61.51 110.906 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.5 21.28 9.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 61.3 110.918 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 m -121.67 160.45 46.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.692 0.758 . . . . 64.12 111.165 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HG23 ' A' ' 42' ' ' VAL . 53.4 Cg_endo -69.75 -169.72 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.691 2.261 . . . . 71.14 112.398 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.25 -61.17 1.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 51.12 111.101 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.63 -50.51 20.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.282 -0.417 . . . . 44.32 110.976 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -97.7 56.6 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 63.42 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.0 p -112.47 172.12 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.134 0.492 . . . . 53.2 110.739 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.1 106.61 3.2 Favored 'General case' 0 N--CA 1.458 -0.043 0 CA-C-N 116.022 -0.535 . . . . 72.32 111.082 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.814 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -116.65 140.68 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 72.23 111.17 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 54' ' ' GLY . 10.6 pt -145.37 159.6 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 63.0 111.104 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -55.74 178.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 51.03 111.113 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -58.09 -49.21 77.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 74.5 110.769 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.22 -25.01 68.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.504 . . . . 74.12 110.741 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 50' ' ' ILE . . . 105.99 19.49 10.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.852 -0.69 . . . . 62.51 112.485 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 81.0 mt -82.35 143.47 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.925 0.393 . . . . 61.01 110.996 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.637 ' O ' HD13 ' A' ' 57' ' ' ILE . . . -54.43 169.93 1.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.918 -0.658 . . . . 65.31 112.716 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' O ' ' A' ' 56' ' ' GLY . 22.4 mm -135.15 152.28 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.868 0.366 . . . . 64.4 111.16 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.05 99.89 11.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.418 0.628 . . . . 74.23 110.905 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.3 -8.89 24.8 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.758 2.305 . . . . 74.3 112.32 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.45 68.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.477 -0.329 . . . . 75.34 110.985 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.85 -177.97 0.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.31 110.857 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -82.84 153.9 24.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.15 111.221 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.44 -58.27 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.11 -47.82 40.54 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.68 -0.772 . . . . 72.15 112.701 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.56 -47.23 82.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.0 0.428 . . . . 61.53 110.949 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 29' ' ' PHE . 38.5 t -68.14 -27.13 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 115.951 -0.568 . . . . 74.04 111.187 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -38.22 72.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 73.24 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.3 -13.03 38.91 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.971 -0.559 . . . . 71.15 110.756 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 -55.69 5.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 73.32 111.04 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -104.25 -38.33 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 55.44 110.888 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.62 148.68 6.06 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.565 -0.826 . . . . 64.21 112.491 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.653 ' O ' HD12 ' A' ' 74' ' ' LEU . 1.6 p -58.92 -19.63 44.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.771 0.32 . . . . 72.41 110.859 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -76.87 100.01 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.13 0.491 . . . . 70.35 110.855 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 49' ' ' ILE . 5.0 mp -121.0 166.32 14.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 75.12 110.855 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' NH2' HD11 ' A' ' 50' ' ' ILE . 1.9 ptt85 -158.98 126.17 4.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 75.22 110.777 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.836 HG21 HG21 ' A' ' 42' ' ' VAL . 3.0 mp -93.07 153.48 3.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.306 -0.406 . . . . 72.44 110.966 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.6 pt -156.95 156.72 30.1 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.665 0.745 . . . . 73.24 111.339 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.51 1.87 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.94 2.427 . . . . 75.05 112.306 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -52.13 -47.17 65.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.39 26.66 1.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.997 -0.547 . . . . 55.15 110.873 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 51.88 84.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.31 111.093 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -169.94 146.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 74.34 111.266 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 120.711 -0.756 . . . . 61.11 112.618 -179.852 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.081 0 CA-C-O 121.516 0.509 . . . . 52.53 112.363 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -178.72 2.44 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.775 2.317 . . . . 74.4 112.286 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 13.2 tp -120.52 -45.67 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 73.32 111.01 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -88.71 -47.25 4.3 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.759 -0.734 . . . . 62.34 112.425 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.2 m 63.1 34.39 13.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 71.03 110.885 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -113.6 57.88 0.68 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.133 -0.485 . . . . 75.41 111.554 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -163.41 73.52 0.32 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.15 -0.477 . . . . 65.44 110.807 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -144.01 159.37 42.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.361 -0.381 . . . . 75.33 110.763 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.18 156.08 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 61.23 111.097 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 110.55 22.97 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.095 -0.502 . . . . 55.43 110.874 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.781 ' CD2' HD13 ' A' ' 74' ' ' LEU . 36.3 t80 -97.3 108.42 21.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 75.23 110.818 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -79.09 129.52 34.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.115 -0.493 . . . . 70.32 111.218 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 36' ' ' ALA . 8.2 tt -117.62 111.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 53.02 110.93 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.04 143.72 49.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.074 -0.512 . . . . 72.52 111.049 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 40' ' ' PHE . 16.5 tp -141.03 -48.82 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 72.43 110.785 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.66 9.66 2.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 73.53 111.141 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.06 16.29 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 63.3 110.846 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 61.4 162.7 0.11 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.31 110.741 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.97 -48.71 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.977 2.451 . . . . 73.41 112.293 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 16' ' ' LEU . 15.2 mtt180 -130.35 65.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 72.32 110.966 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.618 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -170.15 160.39 6.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.63 0.729 . . . . 53.05 110.971 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.618 ' HD2' HD23 ' A' ' 16' ' ' LEU . 52.0 Cg_endo -69.9 -53.15 0.28 Allowed 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.692 2.262 . . . . 72.22 112.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -171.33 165.2 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.01 0.433 . . . . 75.2 110.969 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.607 ' HB3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.54 122.72 44.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 75.44 110.784 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.04 127.59 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 65.11 110.953 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -114.94 175.56 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 75.3 111.023 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -141.7 138.41 32.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 73.24 110.879 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.52 155.38 31.52 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-O 121.481 0.658 . . . . 64.4 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HG2' HG23 ' A' ' 27' ' ' THR . 55.3 Cg_endo -69.41 172.26 12.61 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.952 2.435 . . . . 74.55 112.273 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -85.98 -26.37 25.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 63.02 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -92.98 58.19 2.92 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.03 -0.532 . . . . 74.1 110.839 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -123.78 156.42 65.17 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.454 0.645 . . . . 60.04 111.18 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.824 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 54.0 Cg_endo -70.07 117.24 4.98 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.692 2.261 . . . . 65.1 112.451 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -54.04 -47.18 71.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.31 -0.405 . . . . 73.14 110.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.6 m -62.07 -62.1 2.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.317 -0.402 . . . . 63.4 111.142 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.824 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -49.33 -51.37 34.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.242 -0.436 . . . . 74.11 110.852 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' PRO . 59.0 t -55.16 -42.91 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 55.51 111.101 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -60.08 -66.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 72.43 110.924 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -53.97 -39.74 66.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 71.51 110.802 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -57.47 -66.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.22 110.978 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 8' ' ' ILE . . . -51.12 -56.13 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.08 -0.509 . . . . 72.33 111.277 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.643 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -51.37 -50.22 59.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 64.52 111.147 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.8 -33.82 74.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.976 0.417 . . . . 72.21 111.047 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -25.91 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 65.2 110.937 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 10' ' ' LEU . 0.5 OUTLIER -110.97 25.48 11.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.966 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 65.77 36.2 6.36 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.145 -0.479 . . . . 74.24 110.951 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.759 HG11 HG22 ' A' ' 76' ' ' ILE . 2.8 t -120.74 131.1 24.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 64.32 111.251 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.03 177.49 5.71 Favored 'Trans proline' 0 N--CA 1.471 0.159 0 C-N-CA 122.591 2.194 . . . . 75.32 111.97 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.78 -34.0 4.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 54.03 111.169 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.86 -50.48 14.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 75.4 111.198 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -39.75 25.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 61.32 111.198 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.7 t -114.44 169.66 8.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 65.44 110.723 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' C ' HG23 ' A' ' 76' ' ' ILE . . . -171.64 176.52 3.69 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.901 -0.591 . . . . 72.14 110.941 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.741 HG22 ' CG1' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -84.2 142.83 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.185 0.517 . . . . 74.54 110.846 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.426 HD11 HD11 ' A' ' 77' ' ' ILE . 1.3 pp -142.78 130.76 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.936 -0.574 . . . . 72.4 111.152 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' HIS . 66.2 p -53.28 171.54 0.07 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.376 -0.374 . . . . 64.42 111.167 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -51.89 -40.45 60.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.264 -0.425 . . . . 74.23 111.02 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.83 -25.32 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.625 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.81 19.49 9.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.32 112.413 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.76 144.21 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 70.42 111.185 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 148.81 44.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.793 -0.718 . . . . 55.32 112.725 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.713 HD13 ' CG1' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -81.92 146.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.808 0.337 . . . . 71.31 111.152 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.96 90.65 3.74 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.659 0.742 . . . . 75.34 110.872 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 57' ' ' ILE . 55.3 Cg_endo -69.86 -10.38 28.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.663 2.242 . . . . 73.43 112.388 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.1 -12.03 52.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.162 -0.472 . . . . 52.42 111.227 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -111.87 -178.06 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.236 -0.438 . . . . 73.13 110.762 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.67 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -85.31 165.2 17.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 73.41 111.268 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.57 -62.07 1.76 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.045 -0.525 . . . . 74.53 111.092 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -51.89 -47.62 53.26 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 120.726 -0.75 . . . . 71.1 112.49 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -59.61 -40.24 86.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 75.44 110.794 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 62' ' ' THR . 98.3 t -67.49 -32.84 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 54.23 110.889 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -40.03 68.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 73.21 110.822 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.82 -29.24 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.122 -0.49 . . . . 74.35 110.978 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -33.31 74.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 72.15 110.855 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HB3' HG22 ' A' ' 51' ' ' THR . 94.2 m-70 -102.31 -51.6 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 63.1 110.777 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.77 -95.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.83 -0.7 . . . . 75.4 112.389 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 m -160.93 -40.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.169 0.509 . . . . 72.12 110.966 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.78 102.88 6.45 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.845 -0.616 . . . . 73.23 111.087 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 ' CD2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -118.16 109.59 16.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.175 -0.466 . . . . 74.1 111.019 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.66 HH21 HD13 ' A' ' 77' ' ' ILE . 4.4 ptm180 -104.28 138.91 40.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.93 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.759 HG22 HG11 ' A' ' 42' ' ' VAL . 1.9 mp -105.1 135.82 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.759 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.66 HD13 HH21 ' A' ' 75' ' ' ARG . 0.8 OUTLIER -162.44 158.62 20.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.613 0.721 . . . . 65.12 111.169 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.87 130.84 19.89 Favored 'Trans proline' 0 C--O 1.22 -0.418 0 C-N-CA 122.615 2.21 . . . . 71.24 112.213 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -35.66 6.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 70.45 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -119.59 146.04 45.87 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.336 -0.393 . . . . 73.31 110.917 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 57.9 87.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.08 -0.509 . . . . 75.23 111.029 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 m -114.65 158.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 74.22 110.983 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.291 0 C-N-CA 120.649 -0.786 . . . . 71.53 112.489 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 CA-C-O 121.353 0.418 . . . . 50.43 112.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 141.98 46.4 Favored 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.845 2.364 . . . . 71.45 112.221 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.1 124.74 42.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.058 -0.519 . . . . 54.43 110.887 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -109.13 100.66 1.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 74.42 112.332 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.31 138.85 21.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.844 0.354 . . . . 44.33 110.914 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.98 -57.58 1.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 74.35 110.88 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -125.39 142.34 51.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 52.12 111.053 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.29 174.19 6.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.833 0.349 . . . . 60.43 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 5' ' ' SER . 9.7 p -160.35 158.54 2.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 72.4 111.177 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 4' ' ' VAL . 68.2 m -81.87 161.5 23.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.901 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 74' ' ' LEU . 5.8 t80 -156.84 108.98 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.035 -0.529 . . . . 73.54 110.588 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -95.85 115.47 27.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.907 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' ILE . 10.2 tt -112.31 112.83 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 63.1 111.006 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 18' ' ' TYR . 2.7 p -123.64 135.64 54.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.43 110.905 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -119.49 -11.15 9.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.889 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -162.07 -35.66 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.218 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.74 7.27 6.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 74.24 110.811 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.13 162.63 0.1 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.647 0.737 . . . . 74.22 110.734 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.9 -9.45 26.09 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.871 2.381 . . . . 71.25 112.177 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -163.72 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 75.14 110.822 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -53.91 162.67 1.35 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.495 0.664 . . . . 63.24 111.026 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 16' ' ' LEU . 54.6 Cg_endo -69.48 169.76 17.81 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.649 2.232 . . . . 72.42 112.543 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.591 ' HB2' HG22 ' A' ' 9' ' ' THR . 4.7 p90 -88.55 -175.98 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.879 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.76 119.05 38.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.928 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG23 ' HG3' ' A' ' 7' ' ' LYS . 6.7 p -121.95 127.15 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 73.22 111.077 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -129.16 175.59 8.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.097 -0.502 . . . . 75.53 110.889 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.0 p -124.71 140.04 53.3 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.116 -0.493 . . . . 71.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 m -141.0 155.99 68.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.744 0.783 . . . . 62.24 111.122 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.87 167.63 24.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.523 2.149 . . . . 43.42 112.331 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -85.98 -29.06 23.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.063 0.459 . . . . 72.54 110.818 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 t -97.0 77.07 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 53.54 110.951 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -159.38 158.27 27.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 75.23 111.2 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 32' ' ' VAL . 55.4 Cg_endo -69.66 113.32 3.32 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.537 2.158 . . . . 60.34 112.595 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.701 ' CE2' HG11 ' A' ' 66' ' ' VAL . 71.1 t80 -63.39 -57.67 9.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 74.15 110.841 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 31' ' ' ALA . 3.2 t -50.95 -44.02 60.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.162 -0.472 . . . . 73.33 111.166 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' N ' HG23 ' A' ' 30' ' ' THR . . . -60.35 -59.05 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 71.25 111.076 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 28' ' ' PRO . 72.0 t -57.7 -26.1 26.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.291 -0.413 . . . . 73.23 111.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -69.77 -66.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 75.03 111.236 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -61.5 -34.2 75.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.022 -0.535 . . . . 70.12 110.89 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.38 -55.76 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.805 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.33 96.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.22 111.055 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 42' ' ' VAL . . . -66.36 -37.06 84.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.328 -0.396 . . . . 75.31 111.006 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -52.14 -57.48 9.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.427 -0.351 . . . . 71.01 110.997 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -63.21 -16.58 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.424 ' HB3' HD22 ' A' ' 10' ' ' LEU . 3.2 m-85 -92.43 15.92 12.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.43 . . . . 63.53 111.015 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 mttp 65.29 24.43 12.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 71.04 110.81 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -127.48 103.51 22.33 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.937 0.875 . . . . 71.15 111.28 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.78 -165.54 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 64.23 112.039 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.22 -38.79 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.889 -0.596 . . . . 64.44 111.187 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.92 -50.59 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 74.42 111.214 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -37.31 11.83 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.274 -0.421 . . . . 70.13 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 t -85.06 173.74 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 51.43 110.715 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.55 137.07 20.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 115.868 -0.605 . . . . 72.21 110.986 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.923 HD11 HD23 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -106.44 137.38 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 71.43 111.097 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.74 175.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.11 -0.495 . . . . 71.32 111.229 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.67 -172.27 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 65.3 111.028 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -60.92 -38.62 86.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.779 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.4 23.25 5.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.038 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.85 72.83 0.45 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.69 -0.767 . . . . 42.43 112.582 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -123.1 144.58 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.844 0.354 . . . . 74.52 111.144 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.26 162.57 23.6 Favored Glycine 0 C--N 1.328 0.121 0 C-N-CA 120.699 -0.762 . . . . 65.23 112.232 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.536 HD11 ' CG1' ' A' ' 66' ' ' VAL . 9.9 tp -132.2 153.05 37.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.95 0.405 . . . . 70.15 110.971 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.25 99.06 10.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.456 0.646 . . . . 74.52 110.963 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.635 2.224 . . . . 74.22 112.391 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 69.22 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 70.21 111.376 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -173.85 -169.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.972 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -92.9 151.06 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 65.11 111.077 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.555 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -51.49 -61.64 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.388 -0.369 . . . . 71.01 111.01 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -49.47 -41.91 33.68 Favored Glycine 0 C--O 1.222 -0.606 0 C-N-CA 120.701 -0.761 . . . . 53.13 112.384 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -64.32 -51.68 62.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.833 0.349 . . . . 64.4 110.907 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 62' ' ' THR . 22.2 t -59.24 -52.06 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.125 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CE2' ' HB1' ' A' ' 63' ' ' ALA . 29.6 m-85 -54.93 -44.24 74.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.21 110.923 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -17.0 60.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 74.34 110.955 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -66.4 -52.87 42.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.083 -0.508 . . . . 64.44 110.969 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -94.8 -42.43 8.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.048 -0.524 . . . . 72.1 110.877 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.67 -81.97 0.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.887 -0.673 . . . . 74.1 112.292 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 74' ' ' LEU . 2.2 t 177.16 -32.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 34.34 110.863 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 109.4 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 70.22 110.726 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.923 HD23 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -118.66 163.35 16.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.773 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -159.4 126.35 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.524 . . . . 75.41 110.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' HB ' HG11 ' A' ' 42' ' ' VAL . 2.0 mp -101.86 137.03 31.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.201 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 76' ' ' ILE . 4.7 pt -156.94 157.16 30.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.48 0.657 . . . . 71.52 111.244 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.0 150.01 66.13 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.553 2.169 . . . . 45.13 112.26 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -38.2 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.325 -0.398 . . . . 75.05 110.932 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -84.93 143.98 28.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 64.5 110.868 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 -174.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.41 110.885 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.22 103.48 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.488 . . . . 54.42 111.165 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.746 -0.74 . . . . 65.34 112.618 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' -2' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 121.402 0.445 . . . . 50.41 112.585 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 80.76 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.762 2.308 . . . . 72.05 112.236 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' -4' ' ' GLY . 0.8 OUTLIER -83.8 176.2 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 60.52 110.896 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 164.8 140.39 2.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 74.11 112.465 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.7 p -104.76 93.43 4.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 55.33 110.804 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -145.14 -70.68 0.27 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.101 -0.5 . . . . 70.41 110.914 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -120.93 31.5 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.996 0.427 . . . . 72.22 110.875 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -62.05 148.79 42.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 72.44 110.61 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 p -164.0 150.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 65.31 111.124 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 m -81.14 144.56 31.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.785 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 114.01 11.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 73.24 110.875 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -82.03 118.23 22.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 73.02 110.931 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 76' ' ' ILE . 5.3 tt -129.85 95.17 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 62.51 111.148 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 18' ' ' TYR . 17.9 p -95.94 116.37 28.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.453 . . . . 71.12 111.077 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.617 HD12 ' OG1' ' A' ' 11' ' ' THR . 1.6 pp -69.03 -33.54 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.737 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.617 ' OG1' HD12 ' A' ' 10' ' ' LEU . 96.9 m -117.57 -24.58 7.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 62.54 111.067 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.1 8.23 6.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.942 0.401 . . . . 54.32 110.723 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 176.11 59.13 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.419 0.628 . . . . 73.42 110.667 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.71 -26.27 27.97 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.666 2.244 . . . . 75.44 112.21 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.33 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 73.43 110.902 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -177.56 -61.79 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 40.21 110.97 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 16' ' ' LEU . 53.5 Cg_endo -69.77 -167.72 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.555 2.17 . . . . 73.1 112.329 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.549 ' HB2' HG22 ' A' ' 9' ' ' THR . 10.9 p90 -155.03 171.74 19.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 75.22 110.911 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -102.94 125.12 49.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.055 -0.52 . . . . 70.45 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.4 125.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 54.21 111.079 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD11 ' CZ ' ' A' ' 40' ' ' PHE . 16.9 mt -124.35 123.95 41.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 65.54 110.727 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.4 p -89.14 133.65 34.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.084 0.468 . . . . 44.4 110.916 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 22' ' ' SER . 2.7 m -154.99 156.78 31.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 71.35 111.219 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.66 ' O ' HG22 ' A' ' 27' ' ' THR . 53.9 Cg_endo -69.9 176.75 6.46 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.658 2.239 . . . . 74.41 112.334 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 6.8 pt-20 -85.95 -37.17 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 55.54 110.643 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.8 -32.45 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 74.31 110.794 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' PRO . 9.7 t -71.63 139.89 83.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.44 0.638 . . . . 53.1 111.14 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 31' ' ' ALA . 53.3 Cg_endo -69.6 121.91 8.63 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.562 2.175 . . . . 75.51 112.391 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -58.64 -51.93 67.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.126 0.489 . . . . 74.53 110.9 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -58.7 6.01 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.096 -0.502 . . . . 64.14 111.123 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 28' ' ' PRO . . . -50.07 -52.7 32.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 61.24 111.004 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 28' ' ' PRO . 92.2 t -57.54 -42.46 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.982 0.42 . . . . 71.35 111.063 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.529 ' HG ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -57.19 -66.98 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.432 . . . . 74.34 111.139 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 6.3 ptmt -54.0 -44.74 71.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 73.05 110.86 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -49.69 -69.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.132 0.492 . . . . 63.21 110.957 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.56 73.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 75.1 111.058 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . -49.73 -46.76 50.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 51.54 111.334 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -54.13 -34.71 60.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.073 -0.512 . . . . 63.53 110.766 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.91 -9.5 45.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.87 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' CZ ' HD11 ' A' ' 21' ' ' LEU . 3.4 m-85 -92.88 17.86 9.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.931 -0.577 . . . . 72.44 110.755 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 66.77 18.33 10.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.871 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 ' HB1' ' A' ' 37' ' ' ALA . 2.5 m -123.73 157.39 62.9 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.741 . . . . 71.54 110.901 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 164.9 32.71 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.784 2.323 . . . . 72.52 112.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB1' ' HB2' ' A' ' 34' ' ' LYS . . . -107.43 -49.89 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 73.33 111.102 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.73 -48.69 9.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.208 -0.451 . . . . 32.43 110.984 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 p -92.59 43.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 63.44 111.098 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.15 171.62 7.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.356 -0.384 . . . . 73.3 110.855 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 77' ' ' ILE . . . -134.8 117.0 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 75.11 111.111 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.529 HD13 ' HG ' ' A' ' 33' ' ' LEU . 16.8 mt -94.92 99.41 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 120.994 0.426 . . . . 75.32 111.085 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.76 147.37 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.97 -0.559 . . . . 71.32 111.204 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.603 HG21 ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -91.88 -177.32 4.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 52.0 111.074 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.21 -23.91 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.038 -0.528 . . . . 75.34 110.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.49 15.83 22.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 63.01 110.563 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.65 87.29 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.754 -0.736 . . . . 72.54 112.461 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.5 mt -149.18 144.08 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.839 0.352 . . . . 64.34 111.263 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.13 146.59 14.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.854 -0.689 . . . . 61.34 112.49 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -106.22 156.15 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.846 0.355 . . . . 71.04 111.085 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -103.49 94.19 5.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.539 0.685 . . . . 72.45 110.927 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 58' ' ' ASN . 55.4 Cg_endo -69.65 -9.54 26.41 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.66 2.24 . . . . 54.44 112.399 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.35 65.74 3.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 71.3 111.137 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -177.05 0.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.3 110.905 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -93.46 159.0 15.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 75.3 111.356 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 25' ' ' GLU . . . -50.74 -39.94 53.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 74.13 111.218 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.5 -53.03 48.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.697 -0.763 . . . . 72.23 112.602 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -58.78 -44.08 90.6 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.835 0.35 . . . . 62.44 110.96 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 62' ' ' THR . 20.3 t -69.6 -25.58 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.164 -0.471 . . . . 60.31 111.212 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -73.6 -39.19 64.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.314 -0.403 . . . . 64.21 110.899 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.5 -11.55 37.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 74.2 110.857 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -75.28 -56.08 5.07 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.169 -0.469 . . . . 73.53 111.046 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.603 ' HB3' HG21 ' A' ' 51' ' ' THR . 17.2 m-70 -107.66 -36.51 6.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.871 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.7 145.1 6.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.609 -0.805 . . . . 73.03 112.309 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -28.52 18.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.924 0.392 . . . . 73.33 110.927 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.65 102.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 74.33 110.758 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.16 166.44 24.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 71.32 111.111 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -146.67 160.56 42.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.42 . . . . 63.22 110.828 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 8' ' ' ILE . 25.6 mt -116.15 142.95 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 75.23 111.176 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 48' ' ' ALA . 15.2 pt -152.93 153.31 29.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.483 0.658 . . . . 65.24 111.286 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.6 88.81 0.51 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.705 2.27 . . . . 73.53 112.386 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -75.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.804 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -169.15 61.88 0.05 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 75.54 110.85 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.63 129.8 55.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 72.51 110.865 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 m -73.06 153.99 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.074 0.464 . . . . 74.21 110.99 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 45.41 112.532 179.753 . . . . . . . . 0 0 . 1 stop_ save_